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Executive summary 
DEMOGRAPHICS 
The HIV Futures 7 survey was completed by 
1058 HIV positive Australians from all states 
and territories. This represents approximately 
4.3% of the estimated HIV positive population. 
 § 92.2% were male (975), 6.7% were female 
(70) and 0.3% were transgender (3). 
 § 83.1% were gay men, 6.1% heterosexual 
women, 4.3% heterosexual men, 3.8% 
bisexual men, 0.1% lesbian women and 
0.5% bisexual women. The remaining 2.1% 
fell into other categories.
 § The respondents’ ages ranged 19 to 84 
years with a mean of 49.0 years and 
a median of 49 years. The majority of 
participants were Australian born (78.2%). 
 § Twenty two respondents (2.1%) were of 
Aboriginal/Torres Strait Island origin.
HEAltH 
HIV antibody testing 
 § 24.5% tested for HIV because they became 
ill
 § 18.9% tested as part of routine health 
screening
 § 8.7% tested because they were a member 
of a risk group
 § 10.9% tested because of a particular risk 
episode
 § 2.8% were tested without their knowledge.
Current Health Status 
 § 71.4% rated their health as good or 
excellent and 62.7% rated their general 
well-being as good or excellent.
 § Almost all PLHIV had taken a CD4/T-cell 
test and a viral load test. 
HIV-related and other health conditions 
 § 22.3% of respondents had been diagnosed 
with an AIDS defining illness, 3.3% in the 
previous two years. 
 § 40.6% of respondents indicated that they 
had experienced HIV-related illnesses. 
 § 46.0% indicated that they had a major 
heath condition other than HIV/AIDS. The 
most common conditions were asthma 
(8.3%), cancer (6.4%), cardiovascular 
disease (e.g. high blood pressure) (7.3%), 
type II diabetes (4.2%), hepatitis C (6.0%).
When asked if they had experienced any  
of the following conditions in the previous 
12 months: 
 § 80.2% reported low energy or fatigue
 § 66.8% experienced a sleep disorder
 § 41.9% experienced confusion or memory loss
 § 66.8 % experienced low libido
 § 23.9% reported experiencing 
lipodystrophy/ lipoatrohy
73.9% of respondents reported that they had 
undergone sexual health screening in the 
twelve months prior to survey.
17.5% said they had been diagnosed with an 
STI in the previous twelve months.
Mental health 
 § 34.8% of respondents had taken 
prescribed medication for depression in 
the last six months
 § 48.1% had ever had a diagnosis of a mental 
health condition. 
 § 41.5% of all respondents had ever been 
diagnosed with depression, 17.2% in the 
previous two years. 
Viral Hepatitis 
 § 18.0% had at some point had hepatitis A
 § 60.6% had been vaccinated against 
hepatitis A
 § 18.9% had at some point been diagnosed 
with hepatitis B, of whom:
 § 71.0% had cleared the infection
 § 13.4% had ongoing infection and
 § 5.2% had a chronic infection
 § 68.9% had been vaccinated against 
hepatitis B
 § 15.7% of respondents said they had  
never had hepatitis C.
tREAtMEntS 
Antiretroviral therapy 
Antiretroviral use: 
 § 87.3% were currently using ARV
 § 91.0% had used ARV at some time
 § 80.6% of those on ARV were using  
a pre-formulated combination
Difficulties of taking ARV 
 § 37.6% of those participants currently 
taking ARV reported that they experienced 
difficulties taking them of which the major 
problems were:
 § 21.3% side effects
 § 21.3% remembering to take the drugs on time
 § 13.8% transporting medication
 § 9.9% taking medication in public
 § 11.3% organising meals around the drugs
 § 8.1% taking large numbers of tablets.
Attitudes to antiretroviral therapy 
Does ARV mean better prospects  
for PLHIV? 
 § 86.3% of respondents believed that 
combination antiretroviral drugs mean 
better prospects for PLHIV
 § 8.1% believed that it is still too soon to tell
 § 24.9% believed that combination 
antiretroviral drugs are harmful
 § 29.2% believed that the side effects outweigh  
the benefits of antiretroviral drugs.
Treatment breaks 
 § 27.9% of those currently on ARV had taken 
a break from ARV 
 § Doctors were less likely to be consulted 
before a break than  
during or afterward 
 § 58.3% discussed this with their doctor 
before the treatment break.
Dosing and adherence
 § 48.9% of the sample were taking ARV 
twice daily
 § 2.2% were taking ARV three times a day
 § 47.1% were taking ARV once a day
 § 49.9% said they were taking medication as 
prescribed 100 percent of the time, 79.8% 
said at least 90 percent and 86.9% said at 
least 80 percent. Only 7.4% said less than 
50 percent of the time.
Complementary therapies
 § 62.5% used vitamin and mineral 
supplements
 § 18.2% used herbal therapies
 § 16.5% used marijuana for medicinal 
purposes
 § Complementary therapies tended to 
be used in conjunction with allopathic 
treatment. 
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SERVICES 
Health Services 
 § For HIV specific treatment 51.5% saw an 
HIV GP/S100 prescriber and 26.8% saw an 
HIV specialist/physician 
 § For general health care treatment, 47.3% of 
PLHIV saw an HIV GP/S100 prescriber and 
32.1% saw a non-HIV GP 
 § For 47.8% of respondents, these were 
different doctors. 
Other services 
Services used at AIDS organisations: 
 § 20.0% treatment advice
 § 27.1% social contact
 § 22.3% counselling
 § 18.6% peer support
 § 8.3% advice on legal matters.
Information
Most important source of information on 
treatments/HIV management:
 § 77.0% said HIV GPs/S100 prescribers or 
HIV specialists
 § 7.6% said the internet
 § 5.7% HIV/AIDS organisations 
 § 5.7% HIV magazines and newspapers
 § 0.6% social sources- friends, family etc.
Important sources of information on living 
with HIV:
 § 32.2% said HIV GPs/S100 prescribers  
or HIV specialists
 § 20.7% HIV/AIDS organisations 
 § 14.3% HIV magazines and newspapers
 § 13.0% said the internet
 § 12.5% social sources- friends, family etc.
Involvement with HIV/AIDS 
organisations 
65.0% had some contact with HIV/AIDS 
organisations, mostly receiving newsletters 
or being clients of these organisations. 7.9% 
were employees of HIV/AIDS organisations. 
tHE SOCIAl wORlD Of PlHIV 
Contact with other PLHIV 
 § 92.0% knew another PLHIV
 § 15.0% had a spouse/partner with HIV
 § 49.5% had acquaintances with HIV
 § 70.9% spent at least some time  
with other PLHIV
 § 12.4% spent a lot of time with other PLHIV
 § 29.1% spent no time with other PLHIV
 § 15.5% had been involved with the care of 
someone with HIV/AIDS in the last two years.
For 48.9% of respondents HIV was an 
important part of their identity, while for 
17.5% it was an essential part. HIV status 
tended to be less important than identities 
based on sexuality, gender or family. 
Disclosure 
Almost all respondents had disclosed their 
HIV status to at least one person, generally 
partners, close friends and family. 
For 52.8% of respondents, their HIV status 
had been disclosed to another person when 
they did not want it to be (25.4% in the last 
two years). 
Social support 
Sources of ‘a lot’ of social support: 
 § 77.8% partners/spouse
 § 63.0% pets
 § 43.9% doctors
 § 43.6% close friends
Planning for the future 
19.7% planned only one day at a time, while 
53.3% planned at least one year ahead. 
Relationships and sex 
 § Over one quarter (28.8%) of PLHIV were 
not having sex at present. 41.7 % of PLHIV 
were in a regular relationship, and a 
slightly smaller number had sex within the 
relationship (38.6%). Just under half of this 
group also had sex with casual partners 
(15.4%). 32.7% of respondents had causal 
partners only. 
 § Of those in a regular relationship 40.6% 
had a partner who is also HIV positive, 
57.7% had an HIV negative regular partner 
and 1.6% a partner of unknown status. 
Nearly all (97.5 %) PLHIV had disclosed 
their status to their regular partner. 
 § 31.5% of the respondents had anal or 
vaginal intercourse with a regular partner 
in the past six months. Condom use with 
regular partners was strongly related to 
the HIV-status of the partner. 
 § 48.2% of the sample had sex with casual 
partners in the past six months. 25.9% of 
male respondents reported always using 
condoms with casual male partners. 
Information about the most recent episode 
of sex with a casual partner in the previous 
six months was provided by over half the 
sample. Vaginal or anal intercourse took 
place in 77.2% of these instances. 
Condom use with the most recent casual 
partner: 
 § 9.7% of those who had sex with an HIV+ 
partner
 § 71.2% of those who did not know their 
partner’s HIV status
 § 60.8% of those who had sex with an HIV 
negative partner.
53.7% of PLHIV would prefer to be in a 
relationship with someone who is also HIV 
positive. 60.0% of PLHIV expressed some 
fear of rejection from potential partners if 
they tell of their HIV status. The majority of 
PLHIV (54.2%) felt HIV had a negative effect 
on their sexual pleasure. 
Only 22.8% of PLHIV agreed with the 
statement I feel more confident about 
unprotected sex because of the new 
treatments. 
One quarter of PLHIV agreed that 
undetectable viral load means HIV is unlikely 
to be transmitted (28.1%). 
Legal issues around disclosure
 § 45.2% agreed with the statement I am 
worried about disclosing my HIV status to 
sexual partners because of the current legal 
situation. 
 § 30.1% expressed some concern about the 
legal implications of disclosure of sexual 
practices to service providers.
Recreational drug use 
Alcohol was the drug most commonly used 
by PLHIV (79.5%), and 30.2% had used 
tobacco in the previous 12 months. 
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HOME, wORk AnD MOnEY 
Accommodation 
 § 34.1% were in private rental 
accommodation 
 § 41.5% owned or were purchasing house 
or flat
 § 12.8% were in public rental accommodation 
(government owned)
 § 3.8% were in community housing/housing 
co-operative
 § 41.2% of PLHIV lived by themselves
 § 49.2% of PLHIV lived with pets
 § 76.1% of respondents had access to a car.
Employment 
Just over half of respondents were currently 
in paid employment (58.2%), the majority 
of these being in full-time work (38.5% of 
total sample). The majority of the remainder 
described themselves as either not working 
or retired. 
Most respondents said they had either 
left their career or in some way reduced 
their career goals as a result of their HIV 
diagnosis. 
Around half of respondents who were 
working said that HIV has had an impact on 
their capacity to perform their work duties. 
Most commonly respondents reported 
that they tired more quickly, that they had 
difficulty concentrating and that they have 
had to reduce their work hours. 
54.6% of PLHIV currently in work had not 
disclosed their HIV status to anyone at 
their workplace, while 16.1% did not try to 
keep their HIV status confidential. The most 
common difficulties for those who do want 
to maintain confidentiality at work were 
gossip and explaining absences from work. 
Finances 
47.1% of respondents identified their main 
source of income as a government benefit or 
pension. As well, more than one half of PLHIV 
reported experiencing at least some difficulty 
with meeting the cost of daily living. 
Difficulty with meeting the cost  
of daily living: 
 § 60.4% difficulty paying for utilities
 § 59.8% difficulty paying for clothing
 § 59.3% difficulty paying for housing
 § 52.3% difficulty paying for transport
 § 52.1% difficulty paying for food.
26.6% of those on a government benefit 
had been assessed by a Commonwealth 
Medical Officer in the past 2 years. While this 
resulted in termination of benefits or change 
in conditions for few respondents, it caused 
distress for 58.9% of those assessed. 
Poverty 
28.6% of PLHIV are living below the poverty 
line. Just under one quarter of respondents 
have a partner with whom they share 
financial resources and this protects some 
from extreme economic hardship. Very few 
respondents who are earning an income 
from paid employment reported incomes 
below the poverty line whereas around half 
of those on government benefits are living 
in poverty. 
Discrimination 
 § 7.4% experienced less favourable 
treatment in relation to accommodation, 
2.8% in the last two years 
 § 27.6% experienced less favourable 
treatment because of HIV in relation to 
health services, 13.0% in the last two years 
 § 23.4 % experienced less favourable 
treatment in relation to insurance.
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This section provides an overview of the sample characteristics.  
The data in this section are not weighted. For a full description of the 
project methodology and data weighting algorithms please refer to 
the Appendix. 
Sample demographics 
The HIV Futures 7 survey was completed by 1058 HIV positive 
people. Given current estimates of HIV infection in Australia (Kirby 
Institute, 2012) this represents approximately 4.3% of the HIV positive 
population. Of the total respondents, 36.5% completed a paper copy 
of the survey, while 63.5% completed the survey on-line.
Of the survey respondents, 92.9% were male (975), 6.7% were female 
(70) and 0.3% were transgender (3). This sample consisted of 83.1% 
gay men, 6.1% heterosexual women, 4.3% heterosexual men, 3.8% 
bisexual men, 0.1% lesbian women and 0.5% bisexual women. The 
remaining 2.1% fell into other categories. 
Respondents ranged in age from 19 to 84 years with a mean of 49.0 
years and a median of 49 years. 
The majority of participants were Australian born (78.2%), were 
Australian residents (98.1%) and 96.7% of the participants spoke 
English at home, with Asian and European languages accounting for 
most of the remainder. 
Twenty two respondents (2.1%) indicated they were of Indigenous 
(Aboriginal/Torres Strait Island) origin. This compares to the 
Australian census estimate for 2008 of 2.5% Indigenous status in 
the Australian population (Australian Bureau of Statistics, 2012). 
Respondents came from all Australian states and territories, with the 
majority coming from NSW, Victoria and Queensland (see Table 1 )
Table 1 – State or Territory of respondents’ residence
State/territory Frequency Percentage 
of Sample
NSW 419 40.5
VIC 302 29.2
QLD 138 13.3
WA 71 6.9
SA 54 5.2
ACT 34 3.3
TAS 8 0.8
NT 8 0.8
The majority (59.4%) of respondents were from urban areas of 
capital cities, while 14.9% lived in outer suburban areas, 16.0% lived in 
larger regional centres and 9.7% lived in rural areas. 
69.3% of participants were living in the same state or territory in 
which they were infected with HIV, while 30.7% reported living in a 
different state or territory. 
Table 2 below shows the years in which respondents tested HIV 
positive and in which they believe they were infected with HIV. 
Overall these patterns match those of the Australian epidemic. There 
are 98 respondents in the sample who had tested positive in the 
previous two years (2010-2011/12) and 52 respondents who believe 
they were infected in the previous year (2011/12). 
Table 2 – Years of respondent’s testing positive  
and presumed infection (%)
Year Tested HIV 
Positive
Presumed 
Infected
Pre 1985 5.4 12.4
1985-1989 17.8 16.3
1990-1994 15.0 14.6
1995-1999 13.0 12.1
2000-2004 16.6 18.1
2005+ 32.2 26.6
517 respondents (48.9%) indicated that they were atheist/agnostic, 
34.4% indicated mainstream religious identification and the 
remainder indicated that they either had ‘other’ (9.9%) or New Age 
spiritual beliefs (5.5%). Of those with religious beliefs, 10.3% indicated 
that religious beliefs were not important to them, while 40.4% 
indicated that these were of little importance, 33.9% that they were 
very important and 15.4% that they were extremely important. 
The educational level of respondents to the survey was somewhat 
higher than the general population, as is usual in research requiring a 
moderate level of literacy and engagement with the research process. 
The educational levels are shown in Table 3 below. 
Table 3 – Educational level of respondents
Level Frequency Percent of 
sample
Postgraduate University degree 226 21.6
Undergraduate University degree 200 19.1
Tertiary diploma/ Trade Certificate/TAFE 285 27.2
Leaving certificate/HSC/Year 12 137 13.1
4th form/year 10 125 11.9
Up to 3 years high school 63 6.0
Primary school only 11 1.1
Weighting 
The remaining findings in this report are for weighted data. In order 
to ensure that the results reported in this document accurately 
represent the Australian population of PLHIV, comparisons were 
made to the Australian HIV Surveillance Report (Kirby Institute 2012) 
and the data were weighted to conform to the demographic profile 
of the Surveillance Report. 
A weighting algorithm based on mode of infection, gender, state of 
residence and diagnosis of AIDS defining illness has been applied 
to all the analyses that follow. Consequently, findings are presented 
in terms of sample percentages rather than frequencies. Sample 
sizes (Ns) are given when the table represents a subset of the total 
sample. These Ns are weighted. 
Demographics
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This section of the report deals primarily with the physical health 
and experience of health of Australian PLHIV. The chapter includes a 
discussion of the experiences of testing positive for HIV, the current 
health status of participants measured both by clinical markers and 
self-reported health and well being, the health burden in terms of 
concomitant health conditions and health maintenance strategies. 
HIV AntIBODY tEStInG 
The experience and meanings of testing positive for HIV have 
changed over the history of the HIV/AIDS epidemic. In the early 
years of HIV in Australia, testing did not offer any particularly great 
advantage in treatment options and often led to increased anxiety, 
stigma and discrimination. With the advent of more effective 
treatments, the advantages of early testing have become clearer, 
not only in terms of medication, but also in health monitoring and 
social support. Testing rates remain high among community attached 
gay and homosexually active men in Australia (over 80%), although 
testing is down in Perth and Canberra (NCHSR, 2008).
Since November 2005 HIV antibody testing has been available on 
the Medicare Benefits Schedule and is available free of charge and 
pre- and post-test discussion are integral to the testing procedure 
(Department of Health and Ageing, 2006). 
We asked respondents about a number of circumstances surrounding 
the time that they tested positive for HIV antibodies. 
As can be seen from Table 4, 24.5% of the respondents had taken 
the test as a result of illness, 10.9% as a result of a particular risk 
episode and 8.7% because they were a member of a risk group. It is 
interesting to note that 18.9% gave the reason for testing as routine 
health screening. 
Table 4 – Reasons for testing
Reason Frequency Percent
Became ill/ ongoing illness 255 24.5
Routine health screening 196 18.9
Particular risk episode 113 10.9
Doctor’s suggestion 111 10.7
Partner tested positive 93 8.9
Member of risk group 90 8.7
Other 80 7.7
Tested without knowledge 29 2.8
Starting new relationship 26 2.5
As part of other test/research 20 1.9
Contact tracer/other health worker’s 
suggestion
8 0.7
Required to (e.g. for migration) 5 0.5
Availability of new treatments 4 0.4
Antenatal 4 0.4
Insurance 4 0.4
Pre- and post-test counselling/discussion 
Participants were asked if they had received counselling or had had 
a detailed discussion with their practitioner prior to being tested 
for HIV. Australia’s current HIV testing policy (Department of Health 
and Ageing, 2006) recommends that health care providers engage 
the patient in a discussion that, apart from obtaining the individual’s 
informed consent, also assures them of the confidentiality of the test, 
provides accurate information in a culturally and gender appropriate 
way, and assesses the patient’s readiness for an HIV test. 
As there has been considerable variability in pre- and post-test guidelines 
and practices over the years, we have only asked about the experiences 
of these for people diagnosed in the two years prior to survey. 
22.0% of respondents who had tested positive in the previous 
two years indicated that they had received pre-test counselling 
or engaged in an HIV test discussion. Regardless of whether they 
received formal pre-test counselling or engaged in a discussion, most 
(72.0%) were satisfied with the level of support and information they 
had before testing. Among those unsatisfied with information or 
support many discussed testing that occurred as “routine” associated 
with other medical procedures, or testing carried out in settings that 
had no experience of HIV. 
The national HIV testing policy guidelines (Department of Health 
and Ageing, 2006) recommends that a post-test discussion be 
provided for all individuals who have had an HIV antibody test, even 
if the result is negative. The guidelines recommend that a post-test 
discussion following a negative result reinforce HIV education 
messages about safe behaviours. Positive test results must be 
given face-to-face and the discussion which is aimed at managing 
the impact of a positive diagnosis on the individual, should help to 
identify the patient’s options for support and to provide them with a 
referral to a suitable support agency.
69.9% of respondents who had tested positive in the previous two 
years indicated that they had received post-test counselling. Most 
(76.1%) were satisfied with the information and support they received 
after testing positive. Reasons for dissatisfaction were consistent with 
those around pre-test experiences. 
CURREnt HEAltH StAtUS 
Experience of health and general well being 
We asked respondents how they would best describe their current 
state of physical health and overall sense of well- being on a four 
point scale. The results are shown in Table 5 and Table 6 below. Close 
to half of the sample (45.1%) rated their physical health as good and 
26.3% as excellent. This is less than the Australian population norm 
reported in the 2007-08 National Health Survey (Australian Bureau of 
Statistics, 2009) where 84.9% of the population rated their health as 
good, very good or excellent1. 
Almost one-third of respondents to HIV Futures 7 rated their health 
as fair or poor (28.6%). 
1  It should be noted that the National Health Survey uses a five point scale: 
poor, fair, good, very good, excellent. The figure quoted above is for 
Australians aged 18-64, whereas the HIV Futures 7 sample was aged 18-84.
Health
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Table 5 – Respondents’ self ratings of general health status
Health status Frequency Percent
Poor 72 6.9
Fair 225 21.7
Good 467 45.1
Excellent 272 26.3
The ratings for wellbeing were of a similar pattern to those for health. 
Two thirds (62.7%) rated their wellbeing as either good or excellent, 
while 27.3% rated this as fair and 10.0% as poor. 
Table 6 – Respondents’ self ratings of general well-being
Well-being Frequency Percent
Poor 103 10.0
Fair 282 27.3
Good 435 42.0
Excellent 214 20.7
CD4 and viral load 
As with previous surveys, almost all PLHIV had taken a CD4 T-cell 
test (98.3%) and a viral load test (97.8%) in the previous year. 
Results for PLHIV’s most recent CD4/T-cell test ranged from 10 to 
2600 cells/µl with a mean of 634 cells/µl and a median of 600 cells/µl. 
Results for PLHIV’s most recent viral load test ranged from below 
detectable levels to 5,000,000 copies/ml with a mean of 2,772 
copies/ml and a median of below detectable level. 
Table 7 shows the combined CD4 and viral load results of the sample. 
The results are grouped by three levels of CD4 count: little damage, 
moderate damage and severe damage, and four levels of viral load 
below detectable levels, low, moderate and high. 
As different assays would have been used to assess the respondents’ 
viral loads we have defined below detectable levels as being those 
responses that were less than 500 copies/ml and those where the 
respondent wrote in zero or below detectable level. 
Table 7 – Results of most recent serological tests  
(percentage of total sample) 
HIV VIRAL LOAD 
CD4/Tcell count <500 500-9999 10000 
-49999
50000+ Total
500+ 55.1 1.7 1.7 1.0 59.5
350-499 20.9 1.3 0.9 0.3 23.4
0-349 16.0 0.2 0.3 0.6 17.1
Total 92.0 3.2 2.9 1.9 100.0
HEAltH COnDItIOnS In ADDItIOn tO HIV 
While there is often uncertainty about whether a particular illness 
may be related to HIV, treatments or other factors, we offered 
participants the opportunity to record these conditions within the 
categories of AIDS defining illnesses (ADI), HIV-related illnesses, 
major health conditions other than HIV/AIDS and mental health 
conditions. We asked respondents to indicate whether they had 
experienced conditions in these categories and to specify the 
condition and the year in which it was diagnosed. 
Some recoding was undertaken, for example for a condition that 
did not meet the criteria for ADI, the data were transferred to either 
HIV related conditions or other health conditions. Regardless of the 
uncertainty about the aetiology of these conditions among PLHIV 
(and indeed physicians) we can see that there is a considerable 
burden of illness that goes beyond HIV infection for a significant 
proportion of the survey respondents. 
Participants were also asked to select from a list of 10 HIV-related 
illnesses those that they had experienced in the 12 months prior to 
survey. This section will also cover co-infection with hepatitides, 
attitudes towards body changes and health maintenance activities. 
AIDS definingillnesses 
The Australasian Society for HIV Medicine (Australasian Society for 
HIV Medicine, 2004) lists 26 AIDS-defining conditions in their HIV 
management manual. These include opportunistic infections, as well 
as neurological and malignancy disorders. AIDS-defining illnesses 
are notifiable conditions in all states and territories in Australia, and a 
confirmation of a case requires both laboratory and clinical evidence 
(Department of Health and Ageing, 2004).
The category system for defining the stages of HIV disease 
progression was in large part based on an understanding of the 
progress of the disease as degenerative with little backwards 
movement through the categories. There are now numerous HIV 
positive people who have at some time experienced an AIDS defining 
illness but would now be classed at a less severe stage of disease 
progression. We asked respondents if they have ever experienced 
an AIDS defining illness for 3 reasons: to match and weight the data 
according to surveillance data; to examine issues around the burden 
of illness; and to understand the current health status of participants. 
Around one in five respondents (22.3%) said they had been 
diagnosed with an AIDS defining illness at some point with 3.3% 
having been diagnosed with one in the previous two years (2010 
to 2011/12). The most common illnesses listed by respondents in 
this category were Pneumocystis Pneumonia (148 people), Kaposi’s 
Sarcoma (40 people), and Cytomegalovirus (18 people). 
HIV/AIDS related conditions 
Over forty percent of respondents (40.6%) indicated that they had 
experienced an HIV-related illness at some point. Within this group 
the most common conditions mentioned were dental problems 
(23.6% of respondents ), shingles (19.3%), and skin problems (such as 
rashes) (18.0%). 
In a separate question, participants were asked to select from a list of 
12 conditions commonly associated with HIV infection those that they 
had experienced in the 12 months prior to survey. 
HEAltH
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Table 8 – Health conditions experienced in the past 12 months
Health condition Percent
Low energy/fatigue 80.2
Low libido 66.8
Sleep disorder 63.1
Diarrhoea 61.8
Strange thoughts or dreams 61.8
Confusion/memory loss 41.9
Raised cholesterol/triglycerides 37.2
Nausea or vomiting 34.7 
Weight loss/underweight 28.3 
Peripheral neuropathy 25.3 
Lipodystrophy/lipoatrophy 23.9
Insulin resistance 3.6
Attitudes towards body image 
Lipodystrophy, a side-effect of treatment, is a significant quality of 
life issue for people on treatment. Persson (2004) has pointed out 
that the paradox of ART treatments is that while it removes HIV from 
the inside, for some, it makes it more visible on the outside, making 
the treatment a marker of disease. 
Positive people who experience lipoatrophy have been found 
to score significantly lower than HIV positive people without 
lipoatrophy on a quality of life measure (Rajagopalan et al., 2008). 
These quality of life issues can be significant and Lenert et al (Lenert 
et al., 2002) have found in a study of HIV positive people that most 
would trade years of life to avoid lipodystrophy.
While there is still some debate over the most appropriate clinical case 
definition for these conditions, self reported body changes remain an 
important component of diagnosis (Carr et al., 1999, Behrens et al., 
2000). To assess the impact of these we asked participants to respond 
to a series of statements about their body image.
These are presented in Table 9 (at bottom of page) for both the total 
sample, and for those who indicated that they had experienced 
lipodystrophy or lipoatrophy in the past 12 months. As can be seen, 
approximately equal numbers of the total sample of people agreed 
and disagreed with the other two items, while the responses of those 
with lipodystrophy/lipoatrophy were more likely to be suggestive of 
a poorer body image. 
Other sexually transmitted infections
There has been an increase in the diagnoses of sexually transmitted 
infections (STIs) other than HIV in Australia, and particularly 
syphilis among homosexually active men (National Centre in HIV 
Epidemiology and Clinical Research, 2008). Amongst gay men in 
Sydney, research has found a higher prevalence of some STIs – namely 
syphilis and anal gonorrhoea among HIV positive men compared to 
HIV negative men in Sydney (Jin et al., 2007). 
A similar discrepancy was observed in rates of syphilis amongst 
Melbourne men where the authors estimate that HIV positive men 
were 4.7 times more likely to be diagnosed with syphilis than 
negative men (Allen et al., 2008).
We asked about sexual health screening, and 73.9% of respondents 
reported that they had undergone such a screening in the twelve 
months prior to survey. We included a question in the HIV Futures 7 
survey about sexually transmitted infections that participants may 
have been diagnosed with.17.5% said they had been diagnosed with 
an STI in the previous twelve months.
Table 10 – Participants diagnosed with a sexually transmitted 
infection in past 12 months
Diagnosis Frequency Percent
Gonorrhoea 70 6.7
Chlamydia 97 9.3
Genital Herpes 19 1.8
Syphilis 51 4.8
Other 12 1.2
Table 9 – Attitudes around body image (percentages of total sample, those with and without lipodystrophy) 
Body image attitude % of total sample % of those with 
lipodystrophy
% of those without 
lipodystrophy
Changes in my body due to HIV/AIDS  
have made me feel sexually unattractive
strongly agree 
agree
disagree 
strongly disagree
18.5
34.6
35.1
11.8
36.5
44.6
17.1
1.8
12.4
30.6
41.7
15.3
I am happy with the way my body looks. strongly agree 
agree
disagree 
strongly disagree
7.7
39.4
38.8
14.1
2.3
23.9
46.7
27.1
8.8
45.1
36.2
9.8
Body changes due to lipodystrophy make 
it obvious to others that people have HIV
strongly agree 
agree
disagree 
strongly disagree
13.0
31.0
38.3
17.7
29.1
44.3
22.2
4.4
8.0
26.7
42.1
23.1
HEAltH
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Other health conditions 
46.0% of respondents indicated that they had a major health 
condition other than HIV/AIDS. The most common conditions listed 
under this heading were asthma (8.3%), cancer (6.4%), cardiovascular 
disease (e.g. high blood pressure) (7.3%), type II diabetes (4.2%), 
hepatitis C (6.0% of the total sample).
VIRAl HEPAtItIS
Hepatitis is a term that refers to inflammation of the liver. Six different 
types of viral hepatitis have been identified so far. Hepatitis A, B  
and C are more commonly known in Australia but hepatitis D, E and 
G have also been identified. For HIV positive people, co-infection 
with hepatitis may affect both their health and/or their decisions in 
relation to antiretroviral treatments. We asked about diagnosis of, 
and vaccination against, hepatitis A and B, and some more detailed 
questions about diagnosis and experience of hepatitis C. 
Hepatitis A 
Around one fifth of the participants (18.0%) had at some point had 
hepatitis A, and 60.6% had been vaccinated against this virus. 
Hepatitis B 
A total of 18.9% of respondents had at some time been diagnosed 
with hepatitis B. Of these, 71.0% had cleared the infection, 13.4% had 
an ongoing infection and 5.2% had a chronic infection. In addition 
to those who had experienced hepatitis B infection, 68.9% had been 
vaccinated against this virus. 
Hepatitis C 
Around one quarter (28.4%) of respondents had not been tested 
for hepatitis C. 80.2% of the most recent hepatitis C antibody tests 
were taken in the previous two years and 13.7% of participants’ first 
hepatitis C antibody tests were taken in this period. 
We asked respondents if they had ever had hepatitis C, and 15.7% 
(N=159) said that they had. Of these, 59 people (39.2%) said they had 
since received a negative PCR test. 
When asked how they believe they were infected with the hepatitis 
C virus, 46.5% said injecting drug use, 27.6% during sex, 5.7% blood 
transfusion or the receipt of blood products, and 1.8% through 
tattooing. 6.9% of respondents did not know how they were infected. 
Table 11 – Respondents’ reported mode of hepatitis C infection 
(percentage of those with hepatitis C)
Mode of infection Percent
Injection Drug Use (IDU) 46.5
During Sex 27.6
Don’t know 6.9
Blood transfusion/ Blood products 5.7
Tattooing 1.8
Other 11.6
16 respondents reported that they had completed treatment with 
interferon monotherapy, while 4 were currently on this treatment  
and four had started but not completed monotherapy. 
51 people reported that they had completed combination therapy  
of interferon and ribavirin. 4 were currently on combination therapy 
and 9 had commenced but not completed therapy.
Hepatitis C co-infected participants were also asked about health 
monitoring and management. Around one fifth (23.8%)  
of co-infected PLHIV did not currently see a doctor for hepatitis C 
treatment or management, while 48.5% of this group saw their primary 
HIV doctor and 27.7% saw a separate hepatitis C doctor or specialist. 
Multiple Hepatitis experience 
Co-infection with a hepatitis virus has important implications for 
treatment of both HIV and the hepatitis. Co-infection also results 
in increased clinical management particularly around treatment 
decisions for both conditions, interpretation of clinical markers and 
the management of adverse consequences of treatment. 
Figure 1 below shows the percentage of respondents who reported 
having ever had at least one of the viral hepatitides. This figure 
includes those with current infection and those having had it in the 
past, having reported clearing the hepatitis B virus or testing negative 
on a PCR test for hepatitis C. Of those for whom data was available 
on all three viruses, 19.6% had experience of one form of hepatitis 
infection, 13.8% of two forms and 1.8% had experienced all three. 
Figure 1 – Multiple hepatitides (percentage of respondents)
HEPATITIS A
HEPATITIS B HEPATITIS C
6.6%
(Hep B only)
7.1%
(Hep A only)
5.8%
4.7%
1.8%
5.9% 
(Hep C only)
3.3%
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MEntAl HEAltH 
Mental health issues continue to figure large in discussions of the 
needs and status of positive people in many parts of the world. 
While a survey like this cannot expect to offer a clinical perspective 
on mental health status, we can give an overview of some of the 
experiences of positive people that fall within the broad area of 
mental well-being. 
In a study of major depressive illnesses among HIV positive and 
negative gay men in Sydney and Adelaide, Mao et al (2009) found 
that gay men generally were at high risk of depression whatever 
their HIV status. While being HIV positive was not independently 
associated with an increased risk of depression, positive men had 
higher rates of depression associated with factors such as socio-
economic deprivation, isolation and withdrawal.
Psychiatric medications
In the six months prior to completing the survey, 34.8% of PLHIV said 
they had taken medicines prescribed for depression. This is likely 
to come out as considerably higher than the 5.9% of the Australian 
population who reported having taken antidepressants in the 
previous 2 weeks in the National Health Survey (Australian Bureau of 
Statistics, 2009). 
Diagnosis of a mental health condition
We asked respondents if they had been diagnosed with a mental 
health condition and 48.1% reported that they had had such  
a diagnosis. Of those reporting a diagnosis, the vast majority had 
been diagnosed with depression (87.5%, 41.5% of the total sample). 
17.2% of people receiving a diagnosis of depression reported having 
received this diagnosis in the previous 2 years. 
The next most common condition was anxiety, reported by 57.7% of 
those with a mental health condition (27.4% of the total sample). 20.2% 
of those reported having received this diagnosis over the past 2 years.
HEAltH MAIntEnAnCE 
Attitudes to health management 
Participants responded to a number of statements about health 
management in relation to health improvement strategies, 
antiretroviral therapies and complementary therapies. The items 
on antiretroviral and complementary therapies are presented in the 
relevant sections of the report. 
When asked about health management strategies, almost all 
participants agreed that exercise; healthy eating and an optimistic 
outlook were important or very important strategies (see Table 12). 
Those who indicated that they exercised and ate well were more 
likely to agree with the respective statements.
Table 12 – Attitudes to health management  
(percentage of total sample) 
Attitudes to health management % total 
sample
Looking after my physical 
fitness is an important part of 
managing my HIV infection
strongly agree 
agree
disagree 
strongly disagree
46.7
49.0
3.2
1.1
Healthy eating is an important 
part of managing my HIV 
infection
strongly agree 
agree
disagree 
strongly disagree
43.0
50.3
5.7
1.0
Keeping an optimistic frame of  
mind is an important  
part of managing HIV infection
strongly agree 
agree
disagree 
strongly disagree
13.0
31.0
38.3
17.7
As long as I am well I prefer not 
to think about HIV/AIDS
strongly agree 
agree
disagree 
strongly disagree
24.4
40.1
30.4
5.1
Life has become more 
meaningful since I became HIV 
positive
strongly agree 
agree
disagree 
strongly disagree
13.8
30.0
37.0
19.2
Other health monitoring 
We asked a series of questions about other health monitoring 
activities. 21.3% had had a bone density test in the last two years 
and 14.4% had had a test more than two years ago. 70.2% had had 
a fasting cholesterol test in the last two years and 7.4% had had one 
more than two years ago. 
84.8% had had their blood pressure taken in the previous two years 
and 18.6% had elevated blood pressure. The long term effects of 
living with HIV and medication have made health concerns such 
as high cholesterol, cardiovascular difficulties and osteoporosis 
increasingly important for positive people.
37.1% of all respondents had had an anal pap smear, 64.6% of these in the 
previous year. 98.3% of female respondents had ever undergone a cervical 
smear (Pap) test and 93.2% said they had taken one in the previous two 
years. Of those who had taken a pap test in the twelve months prior to 
survey, most (80.8%) reported that the result was ‘normal’. 
HEAltH
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COMPlEMEntARY tHERAPIES 
We asked participants if they had used any complementary therapies 
in the previous six months, including therapeutic use of marijuana, 
and to indicate the types of therapies used and where these products 
or services were obtained. 
In order to gain an overall picture of the use of these modalities, the 
question asked participants to indicate all complementary therapies 
they had used, not only those used for HIV/AIDS. Over three quarters 
of respondents (73.2%) indicated that they had used some kind of 
complementary medicine or therapy in the previous six months. 
Over half of the sample (62.5%) had taken vitamin or mineral 
supplements. Over one-third (32.8%) of respondents had used 
massage, while 19.9% had used meditation. Around one-fifth 
(16.5%) of respondents indicated that they had used marijuana for 
therapeutic purposes.
Table 13 – Use of complementary therapies in the past six months 
(percentage of total sample) 
Complementary therapies Percent
Vitamin/mineral supplements 62.5
Massage 32.8
Meditation/visualisation 19.9
Marijuana for therapeutic purposes 16.5
Herbal therapies/supplements 18.2
Acupuncture 8.5
Traditional Chinese Medicine 4.2
(Multiple responses possible)
HEAltH
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In this chapter, we report on the treatment experiences of PLHIV. 
As antiretroviral treatments are the main way that HIV is managed 
therapeutically, we focus on participants’ experiences of these, but 
also include a description of the medications that participants take 
for other health conditions.
AntIREtROVIRAl tHERAPY 
Highly active antiretroviral therapy remains the single factor that has 
most altered the clinical outcomes for people living with HIV.
 The introduction of ARV has reshaped the HIV epidemic in 
developed countries, and is increasingly doing so in developing 
nations and resource poor settings. 
In the thirteen years in which these treatments have been available, 
there have been improvements in the efficacy and tolerability of 
treatments, while new combinations of drugs have simplified the 
drug-taking process for PLHIV. 
Nevertheless, being on antiretroviral therapy involves a highly 
structured protocol that requires medication to be taken at specific 
times. Treatment can also result in difficult to manage side-effects. 
In the following section we examine some of these challenges as well 
as the psychological and social impacts of treatment. 
Of the full sample, 91.0% had used ARV at some point, and 87.3% 
were currently using these treatments. A summary diagram of the 
uptake of antiretrovirals can be found below.
Those currently using ARV 
The majority of participants are now taking one of the preformulated  
combinations (Atripla, Truvada, Combivir, Trizivir or Kivexa ) either 
in conjunction with another treatment (N=486) or not (N=243). 
Among those on combinations of individual drugs (N=157), the 
most common combination was one PI and one NNRTI (21 people), 
followed by one PI and an NRTI1 (5 people). 
Table 14 – Antiretroviral drugs used by respondents:  
percentage of those currently using ARV
Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Percent
Lamivudine (3TC, Epivir) 7.7 
Abacavir ,1592 (Ziagen) 3.7
Stavudine, d4T (Zerit) 0.9
Zidovudine, AZT (Retrovir) 4.8
Didanosine (ddI, Videx, Videx EC) 0.9
Zalcitabine, ddC (Hivid) 0.4
Emtriva (Emtricitabine, FTC) 0.7
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Percent
Nevirapine (Viramune) 0.3
Efavirenz (Sustiva, Stocrin) 6.8
Etravirine (Intelence) 5.4
Delavirdine (Rescriptor) 0.1
Nucleotide Analog Reverse Transcriptase Inhibitors Percent
Tenofovir (Viread) 8.5 
Protease Inhibitors Percent
Ritonavir (Norvir) 25.9
Atazanavir (Reyataz) 19.7
Saquinavir (Invirase, Fortovase) 1.4
Nelfinavir (Viracept) 23.1
Indinavir (Crixivan) 0.7
Tipranavir 0.3
Telzir (fosamprenavir) 0.4
Amprenavir (Agenerase) 0.1
Kaletra (Lopinavir + Norvir,)3 8.2
Prezista (Darunavir, DRV) 8.0
Fusion Inhibitor Percent
T-20  0.4
Combination Medications Percent
Atripla (Efavirenz, Emtricitabine and Tenofovir) 20.1
Truvada (Tenofovir, Emtricitabine) 35.9
AZT & 3TC (Combivir) 3.9
AZT & 3TC & Abacavir (Trizivir) 1.3
Kivexa (abacavir and lamivudine) 20.3 
Other Percent
Celsentri (Maraviroc, MVC) 1.7
Isentress (Raltegravir, RAL) 19.9
Other 2.6
fUll SAMPlE
n=1048 2
2   Weighted.
3   Kaletra is counted as 2 protease Inhibitors in calculation of drug combinations, but is listed here under PIs as both drugs are in the same category.
 Note: Ns and percentages may be reduced due to missing data 
Have used 
continuously 
71.6% (N=648) of 
those currently 
using (61.8% of 
total sample)
Have used 
before, but not 
currently 28.9% 
(N=38) of those 
currently not 
using (3.7% of 
total sample)
Have stopped 
at some point in 
the past 27.6% 
(N=250) of those 
currently using 
(23.9% of total 
sample) 
Have never used 
71.2% (N=94) of 
those currently 
not using (9.0% 
of total sample)
CURREntlY USInG ARV
n=905 (87.3%)
nOt USInG ARV
n=132 (12.7%)
Figure 2 – Use of Antiretroviral Therapy
Treatments
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Difficulties of taking ARV 
37.6% of participants who were currently on antiretroviral treatment 
said that they had some difficulty being on treatment. The most 
common problems that participants experienced were remembering 
to take the drugs on time (21.3%) and managing the side effects of 
medication (21.3%). Difficulties transporting their medication (13.8%) 
and taking medication in public (9.9%) were the next most common 
difficulties that participants reported. 
Table 15 – Difficulties of taking ARV among those currently using 
ARV (percentage of those on ARV)
Difficulties of taking ARV Percent
Remembering to take drugs on time 21.3
Side effects 21.3
Carrying/transporting medication 13.8
Organising meals around medication 11.3
Taking medication in public 9.9
Taking a large number of tablets 8.1
ARV drugs make it difficult to take medication  
for other health conditions
4.6
Medication taken for other health conditions  
makes it difficult to take ARV
2.2
Other 4.9
(Multiple responses possible) 
Attitudes to ARV 
Half of respondents were concerned about the future efficacy of their 
treatments: 46.5% agreed or strongly agreed with the statement “I 
am worried that in the future my medication will stop working for me”. 
When asked to respond to the statement “Taking tablets gives me an 
unwanted reminder that I have HIV”, 57.6% indicated agreement and 
40.6% indicated disagreement.
Table 16 – Attitudes to medication:  
percentage of those currently using ARV
Attitudes to 
medication
Strongly 
disagree 
Disagree Agree Strongly 
agree
Don’t 
know
I am worried that 
in the future my 
medication will 
stop working  
for me
10.0 29.8 34.2 12.3 13.6
Taking tablets 
gives me an 
unwanted 
reminder that  
I have HIV
12.4 28.2 35.7 21.9 1.7
Health status of those using ARV 
As expected, those taking ARV had markedly lower viral loads. As 
Table 17 shows, the overwhelming majority of respondents who were 
on ARV had an undetectable viral load at their most recent testing. 
Table 17 – Viral loads of those taking and not taking antiretroviral 
therapy (percentage within rows)
VIRAL LOAD ON MOST RECENT TEST
ARV use 50000+ 10000 
-49999
500 
-9999
Below 
detectable 
levels
Current 0.5 0.8 1.1 97.6
Past 13.0 13.0 17.4 56.5
Never 20.0 32.0 32.0 16.0
χ 2 (3,2) = 469.869, p<0.001 
Those taking ARV and those who had never taken it were more likely 
to have a CD4 count over 500 than those who had previously. 
Table 18 – CD4 of those taking and not taking antiretroviral therapy 
(percentage within rows)
CD4 ON MOST RECENT TEST 
ARV use 0-349 350-499 500+
Current 20.2 22.2 57.7
Past 21.2 42.4 36.4
Never 11.4 22.7 65.9
χ 2 (2,2) = 12.571, p=0.014 
Those who have never taken ARV were less likely to have had an AIDS  
defining illness (1.1% compared to 24.8% among those currently taking  
antiretroviral treatments and 20.5% among those currently not taking 
antiretrovirals ). 
When asked to rate the effect of commencing ARV on their physical 
health, 47.8% said that their health improved, 24.0% said it had 
fluctuated, 22.3% said it had stayed the same and 5.9% said it had 
deteriorated.
When asked about the impact of ARV on their overall feeling of well-
being, 41.1% said it had improved, 30.1% said it had fluctuated, 22.2% 
said it had stayed the same and 6.6% said it had deteriorated. 
Figure 3 – Effect of commencing antiretroviral medication on health 
and wellbeing (percentage of those taking ARV)
Stayed the same
Improved
Fluctuated
Deteriorated
 Wellbeing   Health
0% 10% 20% 30% 40% 50%
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tHOSE nOt CURREntlY tAkInG ARV 
Of the 12.7% of the sample who were not using any antiretrovirals, 
28.9% (N=38) had done so in the past. At the time that they stopped 
using ARV, most were using a combination of 3 drugs. 
Reasons for stopping ARV treatment
Just as the side effects of medication was one of the main difficulties 
that participants on ARV experienced, this was the most common 
reason that those who were not currently on treatment gave for 
stopping ARV therapy (18.1%). 
A sizable number (15.4%) also said that they had stopped treatment 
because their doctor had recommended it. (See Table 19).
Table 19 – Reasons for stopping ARV among those who have 
stopped ARV treatment
Difficulties of taking ARV Percent
Side effects 18.1
Recommended by my doctor 15.4
Difficulty organising meals around medication 4.8
Difficulty taking medication in public 2.7
Taking part in a clinical trial 2.2
Difficulty taking a large number of tablets 2.1
Difficulty carrying/transporting medication 0.0
Other 16.8
(Multiple responses possible) 
Those who have never used  
antiretroviral drugs 
9.0% (N=94) of the respondents had never used antiretroviral treatments. 
Of these 86.1% said they would consider using antiretroviral drugs in 
the future.
AttItUDES tO AntIREtROVIRAl tHERAPY 
Antiretroviral treatments have an impact on many parts of people’s 
lives, not just on their physical health. As in previous surveys, we 
asked respondents to respond to a series of statements about 
treatments. These fall into three broad areas: decision making around 
treatments, relationship with their doctor, and optimism about 
treatments. These findings can be seen in Table 20 below. 
Treatment decision making 
Most respondents indicated that they disagreed with the statement 
I am healthy now and don’t need to use antiretroviral drugs (81.7%). 
Those who agreed with this statement were more likely to be those 
not currently using any antiretroviral drugs and who rated their 
physical health more positively. 
Relationship with doctor 
As with previous surveys, most respondents (88.3%) agreed with 
the statement My doctor and I work together to find the best 
treatment for me, with few expressing uncertainty. Most respondents 
(82.5%) agreed with the statement My doctor knows more about the 
treatment of HIV than I do. 
Treatment optimism 
Optimism about the value and effectiveness of antiretroviral 
treatments continues to characterise the Australian experience, but 
tempered as always with concerns about the impact and long term 
effectiveness of these treatments. 
Only 4.3% of respondents agreed with the statement Combination 
antiretroviral drugs are ineffective. This belief in effectiveness is 
tempered by an awareness of the potential harm of these therapies 
as evidenced by the agreement with the statement that Combination 
drugs are harmful (19.1% agree, 5.8% strongly agree). 
This harm may in part be that experienced as side effects. Around 
one in five (29.2%) respondents agreed or strongly agreed with 
the statement The side effects of antiretroviral drugs outweigh the 
benefits, while 9.5% were unsure.
tREAtMEntS
Table 20 - Attitudes to antiretroviral drugs: percentage of total sample
Attitudes to medication Strongly 
disagree 
Disagree Agree Strongly 
agree
Don’t 
know
I am healthy now and don’t need to use combination antiretroviral drugs 51.8 29.9 7.2 6.4 4.7
Combination antiretroviral drugs are harmful 31.3 29.3 19.1 5.8 14.4
Combination antiretroviral drugs are ineffective 57.5 29.9 1.7 2.6 8.4
New treatments will be developed in time for me to gain benefits 5.9 7.1 42.3 22.7 21.8
HIV treatments will stop me dying from AIDS 5.1 13.6 31.4 32.3 17.6
My doctor knows a lot more about the treatment of HIV than I do 5.2 9.4 37.9 44.6 2.9
My doctor and I work together to find the best treatment for me 4.2 5.4 41.4 46.9 2.1
The side-effects of antiretroviral drugs outweigh the benefits 26.4 34.9 17.0 12.2 9.5
Medical treatments for HIV/AIDS make safe sex less important than it was 39.9 35.4 14.9 4.2 5.6
Undetectable viral load means HIV is unlikely to be transmitted to a sexual 
partner even if I have sex without a condom
29.5 34.9 23.4 4.7 7.5
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There was considerable uncertainty about the long term benefit of 
treatment. 21.8% of respondents said they were unsure when asked 
to respond to the statement New treatments will be developed in 
time for me to gain benefits, with most of the remainder agreeing. 
Similarly, 17.6% were uncertain when asked if HIV treatments will stop 
me dying from AIDS. Agreement with this statement was indicated by 
63.7% of respondents. 
In addition to these items, respondents were asked to indicate how 
much they agree with the statement Antiretroviral drugs mean better 
prospects for most people. Most (86.3%) agreed with the statement. 
Figure 4 – Respondents’ response to the statement Antiretroviral 
drugs mean better prospects for most people
tREAtMEnt BREAkS
Treatment breaks may take a number of forms and be undertaken 
for a range of reasons (Grierson et al., 2004b). While there is 
considerable discussion in the medical community about the 
potential benefits and dangers of treatment interruptions, our main 
emphasis is on the motivations, experiences and consequences of 
breaks for HIV positive people. To understand the experience of 
breaks, we asked respondents to give us some detailed information 
about their most recent break. 
In all, 27.9% of those respondents currently using antiretroviral 
medication had taken a break from these at some point. 
Most recent treatment break 
The date of the commencement of most recent treatment break 
was provided by 88% of those that had ever taken a break. Of these 
24.8% had taken their most recent break in the two years prior to 
survey and 16.7% in the previous one year. 
We asked participants to describe the reasons for taking the break 
within two major categories: lifestyle and clinical reasons. 
A discussion of the differences between those who take treatment 
breaks for lifestyle reasons and those who take breaks for clinical 
reasons can be found in our article on this topic (Grierson et al., 
2004b). Just under half (52.3%) indicated that there were lifestyle 
reasons for taking a break. 
Of those taking a break in the previous two years, 65.8% said there 
was a lifestyle reason. The specific reasons are given in Table 21 
below. The most common reason given was travel (17.8% of those 
taking breaks) followed by to clean out the system (16.3%). 
Table 21 – Lifestyle reasons for taking breaks (percent of those 
taking breaks and percentage of those taking a break in the 
previous 2 years)
Lifestyle reasons for taking breaks Total 
taking 
breaks
Last two 
years (n=41)
Travel 17.8 13.7
Clean out my system 16.3 12.2
It didn’t fit my lifestyle 7.9 11.2
Taking drugs at the right time was too 
difficult
9.8 12.3
The financial burden became too heavy 8.2 18.1
A special event 3.7 12.0
Other 30.0 37.9
(Multiple responses possible) 
When asked if there was a clinical reason for taking the break, 38.5% of 
those that had taken a break indicated that there was. Of those taking a 
break in the previous two years, 30.8% said there was a clinical reason.). 
Table 22 below details the clinical reasons for breaks. The most commonly 
cited reason was that the side effects of treatment became too severe 
(17.5% of all those taking breaks), 11% indicated that the break was on the 
recommendation of their doctor. 
Table 22 – Clinical reasons for taking breaks (percent of those taking 
breaks and percentage of those taking a break in the previous 2 years)
Clinical reasons for taking breaks Total 
taking 
breaks
Last two 
years (n=19)
Side effects became too severe 17.5 17.5
Recommended by my doctor 11.0 4.9
Drug resistance developed 5.7 1.5
Changing regimens 2.9 1.5
Liver toxicity problems 5.4 3.3
Taking part in a clinical trial 2.6 0.0
Recommended by other health professional 0.4 1.5
Complications with Hep C 1.6 0.0
Other 12.3 17.8
(Multiple responses possible) 
We also asked about the involvement of the participant’s doctor 
in these breaks. Participants were less likely to have talked to their 
doctor about the break prior to taking it (58.3%) than they were 
during the break (57.2%) or afterwards (90.7%). 
For those taking a break in the previous two years, fewer talked to 
their doctor about the break prior to taking it (28.2%) during the 
break (42.2%) and afterwards (82.0%). 
We were also interested in the outcome of the treatment breaks, 
both in terms of clinical markers and experience of health and 
well-being. Around two fifths of respondents said that their health 
remained stable, 27% said their health worsened, while 20% reported 
fluctuating health and 12% improved health. 
When asked about their general well-being, a similar proportion said 
that it had remained stable (35.8%). 
Don’t know
It’s too soon to tell
Yes
No
0% 20% 40% 60% 80% 100%
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Table 23 – Effect of break on health and well being  
(percentage of those taking break and percentage in last 2 years)
Effect of break on 
health and well 
being
Health Well being
All last 2 years All last 2 years
Stayed the same 40.1 49.2 35.8 42.4
Improved 12.4 12.5 24.0 19.1
Fluctuated 20.0 22.3 21.5 18.6
Got worse 27.4 16.1 18.7 19.8
The impact of these breaks on clinical markers was less positive. The 
majority of respondents indicated that their viral load had increased, 
and their CD4 count had decreased as a result of the break. These 
data are presented in Table 24.
Table 24 – Effect of break on viral load and CD4  
(percentage of those taking break)
Change in viral load due to break Percent
Decrease (improve) 5.4
Stay the same 20.1
Fluctuate 9.6
Increase (worsen) 64.9
Change in viral load due to break Percent
Increase (improve) 6.3
Stay the same 21.6
Fluctuate 10.8
Decrease (worsen) 5.4
DOSInG AnD ADHEREnCE 
Adherence to the antiretroviral treatment regime is important 
for treatment to be effective and to prevent the development of 
resistance to medications. The degree of adherence required is far 
greater than that of other health conditions. It is estimated that for 
the majority of people on antiretroviral treatments, adherence of 
more than 95% is necessary for successful viral suppression and 
immune response (Chen et al., 2007).
While the consistency of adherence directly affects the health 
outcomes for PLHIV, many factors can have an impact on 
consistency. These include the complexity of the drug regime, a 
person’s emotional well being, the management of side effects, 
lifestyle fit, and communication with friends and doctors (Beusterien 
et al., 2008). 
One study has found that adherence consistency tends to decrease 
over time (Mannheimer et al., 2002) 
Respondents were asked the number of times they took a range of 
medications per day. On average, PLHIV were taking medication 
twice a day (range 0 to 23, median=2). The number of times they 
were taking specific types of medication is shown in Table 25 below. 
48.9% of the sample were taking ARV twice daily, 2.2% three times a 
day and 47.1% once a day.
Table 25 – Number of times participants take medications  
(for those taking class of medication)
Medications Mean Median Range
Antiretroviral drugs 1.63 2.00 1-10
Complementary therapies 1.69 2.00 1-7
Medication for other health 
conditions
1.80 1.00 1-11
Participants who were currently using antiretroviral medication were 
asked over the past month, what percent of the time they were able to 
take their antiretroviral medications exactly as the doctor prescribed 
them. 49.9% said 100 percent of the time, 79.8% said at least 90 
percent and 86.9% said at least 80 percent. Only 7.4% said less than 
50 percent of the time.  
PRESCRIPtIOnS 
We asked participants who prescribed their antiretrovirals. 
In recognition of the multiple prescribing sites people utilise, 
respondents were able to nominate more than one source. 
Over half (53.4%) of PLHIV got their prescriptions for antiretroviral 
drugs from a GP who specialises in HIV/ S100 prescriber. 
A smaller proportion (26.5%) obtained their prescription from a 
specialist in an outpatient clinic, while fewer obtained them from  
a doctor at a sexual health centre (22.7%), another GP (1.2%), or  
from a HIV specialist while an inpatient (2.9%). 
Overall 69.2% were satisfied with their current prescribing 
arrangement, with many indicating a preference for using a local 
pharmacy to collect medication, rather than the more limited 
arrangement currently in place. 
tREAtMEntS
HIV Futures Seven – The Health and Wellbeing of HIV Positive People in Australia, ARCSHS 201313
 
This section discusses the engagement of PLHIV with a range of 
services. A key component of the Australian response to HIV has 
been the establishment of HIV specific services, both within health 
systems (specialist HIV wards in hospitals, high HIV caseload general 
practitioners and sexual health services for example) and through 
community and volunteer organisations. There has also been 
considerable energy expended on sensitising mainstream services to 
issues specific to HIV/AIDS and the affected communities. 
HEAltH SERVICES 
Treatment 
We asked respondents to identify the physician they see for the 
clinical management of their HIV and for general health issues. 
HIV GPs (S100 Prescribers) were the key physicians for both HIV 
specific and general health management. HIV specialists were also 
the primary providers for a significant proportion of PLHIV. The 
distinction between these categories reflects the different healthcare 
systems in different states and territories, and the availability of 
these physicians in regional areas. HIV GPs were more likely to be 
nominated as the primary provider of both general and HIV-related 
treatment by those living in the inner suburbs of capital cities, than 
those living in the outer suburbs, regional centres or rural areas. 
Combined, HIV GPs and specialists were the primary physicians for 
78.3% of respondents for HIV specific management and for 55.0% of 
respondents, for general health management. 
Table 26 – Physician used for general and HIV related treatment: 
percentage of total sample
Physician used For general 
treatment
For HIV 
specific 
HIV GP/S 100 Prescriber 47.3 51.5
Other GP 32.1 3.4
HIV specialist 7.7 26.8
Doctor at sexual health centre 7.0 14.8
Other doctor 2.1 0.5
Other 3.7 3.0
52.2% of respondents said that the doctor they saw for general 
medical services was the same doctor they saw for HIV-related 
treatment. Of those who saw a different doctor, 97.5% said that that 
doctor knew their HIV status. 
Services used at HIV organisations 
Participants were asked whether they were currently using a range 
of services through an HIV/AIDS organisation. Social contact with 
other PLHIV was the most commonly cited use with over one quarter 
of respondents selecting this item. HIV/AIDS organisations were also 
used for counselling, treatments advice, and pharmacy services by 
substantial numbers of respondents. 
Table 27 – Percent of respondents who use services through  
HIV/AIDS organisations
Service Percent
Social contact with other PLHIV 27.1
Counselling 22.3
Treatments advice 20.0
Pharmacy services 27.1
Peer support 22.3
Financial assistance 20.0
Legal advice 27.1
Financial advice 22.3
Other 20.0
(Multiple responses possible) 
InfORMAtIOn
One of the most distinctive characteristics of the HIV/AIDS epidemic 
has been the degree to which those infected with the virus have 
become highly active health consumers. 
This is reflected not only in the emergence of a strong community 
sector and advocacy structure, but also in the way in which individual 
positive people actively engage with their healthcare providers and 
actively seek out a diverse range of information on clinical and social 
aspects of the virus and the epidemic. 
Clinical information and most specifically information on the efficacy 
and consequences of treatment in the HIV/AIDS area is not the sole 
province of health professionals. 
In the previous HIV Futures surveys and in other research we have 
conducted, we have demonstrated that positive people access 
information on HIV treatments, management and social aspects from 
a range of sources including the medical literature, the community 
sector, health professionals and peers. 
Sources 
Respondents were asked to nominate from a list of potential sources, 
those that were important sources of information on HIV including 
treatments management, and living with HIV. 
Table 28 – Sources of information about treatments  
and living with HIV (percentage of sample)
Source Percent
HIV Doctor (specialist or HIV GP/S100 prescriber ) 92.1
Publications from HIV or AIDS groups 53.8
Internet 50.7
HIV or AIDS community organisations  
(for example, Positive organisations, AIDS Councils etc.)
48.8
Social sources  
(HIV-positive friends, other friends, family etc.)
36.4
Other healthcare professional 23.4
Publications from other sources 15.8
(Multiple responses possible) 
Services
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Information about HIV treatment  
and management 
When asked in a separate question to nominate their most important 
sources of information about treatments and health management, 
77.7% of respondents nominated their HIV doctor (GP or specialist) 
as the most important source, followed by the internet (7.6%). 
Information about living with HIV 
When asked to identify the most important sources of information 
about living with HIV, 32.2% nominated their HIV doctor (GP or 
specialist), and 20.7% said HIV or AIDS community organisations . 
Table 29 – Most important sources of information about treatments 
and living with HIV (percentage of sample)
Most important sources HIV Treatment 
and 
Management
Living with 
HIV 
HIV Doctor  
(specialist or HIV GP/S100 prescriber )
77.0 32.2
Internet 7.6 13.0
HIV or AIDS community organisations  
(for example, Positive organisations, AIDS 
Councils etc.)
5.7 20.7
Publications from HIV or AIDS groups 5.7 14.3
Publications from other sources 1.4 1.6
Other healthcare professional 1.1 2.2
Other 1.0 3.5
Social sources  
(HIV-positive friends, other friends, family etc.)
0.6 12.5
Lack of information 
We asked respondents whether lack of information made it difficult 
for them to make decisions in certain areas and over a quarter (28.7%) 
agreed that this was the case. When asked to identify the domains 
in which this applied, employment and financial planning also 
figured prominently, with 13.0% of respondents identifying lack of 
information about work/employment and 12.4% financial planning. 
In the clinical realm, 14.8% nominated the management of side effects, 
while 13.8% nominated interactions between ARVs and other drugs 
Information about complementary therapies was identified by 12.3%.
Table 30 – Issues where participants lack information  
(percent of total sample)
Issues Percent
Managing ARV side effects 14.8
Interaction between ARV and other drugs 13.8
Work/employment 13.0
Financial planning 12.4
Legal issues 12.3
Using complementary therapies 12.3
Changing ARV 10.5
Using ARV 9.6
Taking a break from ARV 8.7
Recreational drug use 6.3
Having children 4.3
(Multiple responses possible) 
InVOlVEMEnt wItH AIDS ORGAnISAtIOnS 
Participants were asked about their involvement with HIV/AIDS 
organisations. 65.0% of the sample had some contact with HIV/AIDS 
organisations. 
Of these, 63.8% received newsletters and mail outs, 54.1% were 
clients, 45.8% were members, 35.8% accessed information on 
websites, 14.5% were volunteers and 7.9% were employees. 
Of those that volunteered, they did so for between 1 and 45 hours 
per week (median = 4 hours/week).
SERVICES
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This chapter examines the collective experience of HIV from  
a number of perspectives. While for some people HIV may be  
a profoundly isolating experience, within Australia the experience  
of HIV has been overwhelmingly a collective one. 
HIV is not only experienced by individuals, but also by communities 
and social networks. HIV identity is managed though contact with 
other positive people, through the disclosure of status, both willingly 
and unwillingly, and through engagement with the community sector. 
Here we explore some of these issues through the experiences of the 
respondents to this survey. 
COntACt wItH OtHER PlHIV 
Very few HIV positive people (8.0%) did not personally know anyone 
else with HIV. Gay men were significantly less likely to know no-one 
else with HIV than other respondents. Most positive people had an 
HIV positive friend (73.2%) and many had either an HIV positive 
partner or ex-partner (15.0% and 25.1% respectively). 15.5% of 
respondents had been involved in the nursing or care of another 
positive person at some time in the last two years. 
Table 31 – Other HIV positive persons known by respondent
Positive Persons Percent
Friend 73.2
Acquaintance/Member of support group 49.5
Former partner/spouse 25.1
Partner/spouse 15.0
Other relative 3.6
Son/daughter 0.7
Online friend or buddy 30.0
Other 6.0
No-one 8.0
(Multiple responses possible) 
Two thirds of the respondents spent at least some time with other 
positive people (70.9%). The 12.4% who indicated that they spend a 
lot of time with other PLHIV were more likely to be those who work 
or volunteer for an HIV/AIDS organisation. 
Figure 5 – Time spent with other positive people
DISClOSURE 
Respondents were asked who they had disclosed their HIV status to 
(see Table 32). Not surprisingly, most (79.9%) had disclosed to close 
friends, and most (90.2%) of those in relationships had disclosed to 
their partner. 
Within families, people were most likely to have disclosed to siblings 
(55.8%) although many had disclosed to parents (43.9%). Only 3.8% 
had not disclosed their HIV status to anyone. 
Table 32 – People the respondent has disclosed their HIV status to
People the respondent  
has disclosed to
Percent
Close friends 79.9
Positive friends 60.9
Siblings 55.8
Partner/spouse 50.5
Parents 43.9
Other friends 28.9
Work colleagues 27.6
Son/daughter 9.4
Neighbours 15.2
People from own ethnic community 5.5
No-one 3.8
Specific sub-populations
Partners (% of those in a regular relationship) 90.2
Work colleagues (% of those currently employed full time) 31.5
Work colleagues (% of those currently employed part time) 37.9
Son/daughter (% of those with children) 48.8
(Multiple responses possible) 
Unwanted disclosure 
Respondents were asked if their HIV status had ever been disclosed 
without their permission. 52.8% said that it had at some point, and 
25.4% said that this had happened in the previous two years. 
When asked if this disclosure had a negative effect, 67.5% said it 
had. When asked who disclosed their status, they were most likely to 
nominate friends. (see Table 33). In part these data reflect those that 
are most likely to be aware of the respondent’s HIV status. 
 A lot
 Some
 A little
 None
0% 10% 20% 30% 40% 50%
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Table 33 – Sources of unwanted disclosure  
(percentage of those experiencing unwanted disclosure)
Sources of 
unwanted  
disclosure
Percent of those who have 
ever experienced unwanted 
disclosure (N=542)
Percent of those who have 
experienced unwanted 
disclosure in the last 2 years 
(N=261) 
Close friends 13.4 24.7
Other friends 12.9 26.6
Work colleagues 8.9 16.0
Partner/Spouse 6.0 10.7
HIV positive 
friends
7.2 17.3
Other 8.9 25.2
Sibling 5.7 9.8
Workers in a 
healthcare setting
7.3 14.3
Parents 4.2 6.6
Neighbour 3.1 6.5
Other family 
member
4.4 9.6
Staff/volunteers 
at community 
organisation
4.2 8.6
Son/daughter 0.8 1.2
People from ethnic 
community
0.9 1.8
(Multiple responses possible) 
The place of HIV in people’s lives 
HIV affects many parts of people’s lives in both positive and 
negative ways. Knowledge of one’s HIV status can be something that 
dominates some people’s sense of who they are, while for others it 
will be a minor facet of their self-image. These different experiences 
of HIV status can have significant implications for the provision of 
services and the targeting of education for positive people. 
To explore this issue, we asked When you think of all the things that 
make you who you are, how important are each of the following 
aspects of yourself? The categories and results are given in Table 34.
A rating of 'essential' indicates that the characteristic is an essential 
component of the individual’s identity. 
A rating of 'important' indicates that the characteristic plays a large 
part in how PLHIV see themselves, but may have greater or lesser 
relevance depending on the context.
A rating of 'not important' indicates that the characteristic only has 
very context specific relevance and does not generally enter into 
their self-image. 
A rating of 'irrelevant' indicates that the characteristic plays no part 
in their self-image. 
While our primary focus in this area was on the importance of HIV 
identity, we have included other characteristics, both as points of 
comparison and as a way of more fully describing PLHIV. 
The characteristics examined were sexuality, gender, recreational 
drug use, ethnicity, parenthood and career. 
Almost half (48.9%) of positive people in this study considered their 
HIV status an important, but not essential aspect of their make-up, 
while 17.5% considered it to be an essential characteristic. This is in 
contrast to sexuality and gender, where around 30% of the sample 
considered each of these to be essential characteristics. 
Social support 
We asked participants about the amount of social support they 
received from a range of sources including household members, 
social contacts and service providers.
The ratings are shown in Table 35 below with those for whom the 
category was not applicable excluded from each row. Participants 
were most likely to have nominated their partner or spouse as 
providing a lot of support (77.8% of those with partners), followed  
by their pets (63.0% of pet owners). Around half of participants  
also received a lot of support from their doctors (43.9%) and close  
friends (43.6%).
Table 34 – Importance of personal characteristics to respondents’ 
sense of identity
Importance of  
personal 
characteristics
Essential Important Not 
important
Irrelevant
Sexuality 30.6 45.5 15.0 8.9
Family 27.6 46.6 15.7 10.1
Gender 29.8 40.8 16.4 13
HIV status 17.5 48.9 21.2 12.4
Career 16.2 44.6 19.0 20.3
Religious beliefs 7.1 20.6 26.7 45.6
Parenthood 7.9 14.3 19.1 58.7
Ethnicity 5.9 24.0 32.1 38.1
Drug use (rec/illegal) 2.8 13.1 30.1 54.0
Table 35 – Social support received from different sources:  
percent who gave valid responses for each category
Importance of personal 
characteristics
A lot Some A little None
Partner/spouse 77.8 10.3 5.5 6.3
Pets 63.0 19.8 9.8 7.4
Doctor 43.9 32.4 20.0 3.6
Close friends 43.6 29.8 17.8 8.7
Parents 31.7 24.3 16.9 27.0
Children 32.6 16.7 14.4 36.3
HIV positive friends 28.1 32.6 28.4 10.9
Family 25.2 22.2 27.6 25.0
Siblings 24.1 22.5 24.5 28.8
Health care workers 23.4 30.9 23.6 22.1
Counsellor 26.3 25.0 22.6 26.1
Volunteer carer 18.4 9.9 12.4 59.3
Religious or spiritual 
advisor
18.5 18.2 15.4 47.9
Online Buddy 13.2 27.5 35.6 23.8
PLHIV groups 13.1 22.1 33.3 31.5
tHE SOCIAl wORlD Of PlHIV
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When we examine the sources that people rated as providing no 
support, the highest ranking category was volunteer carer, where 
59.3% of those with a carer said they received no support from them. 
Religious or spiritual advisors were also considered a source of no 
support for 47.9% of those with such a source. 
Participants were more likely to have rated a source as supportive if 
they had disclosed to them for all categories (except pets). 
Attitudes to HIV status 
Two additional items were included that examine individual’s 
relationship to their HIV serostatus. Participants were asked whether 
they agreed with the statement As long as I am well I prefer not to 
think about HIV/AIDS. Over half the respondents agreed or strongly 
agreed with this statement. The second statement participants were 
asked to respond to was Life has become more meaningful since 
I became HIV positive. 43.8% agreed or strongly agreed with this 
statement. See Table 36 below
Table 36 – Attitudes to HIV status
Attitudes to HIV status Strongly 
agree 
Agree Disagree Strongly 
disagree
As long as I am well I 
prefer not to think about 
HIV/AIDS
24.4 40.1 30.4 5.1
Life has become more 
meaningful since I 
became HIV positive
13.8 30.0 37.0 19.2
Planning for the Future 
A core concern of the HIV Futures surveys is how people with HIV 
view their future, particularly how far into their future they plan. One 
fifth (19.7%) planned their life one day at a time and 27.0% planned 
only a few months ahead. Over half of the respondents planned for at 
least a year with 20.0% planning one year ahead, 21.9% planning five 
years ahead and 11.4% planning ten years or more ahead. 
This profile of the population has changed very little since the first 
HIV Futures survey. Those with longer time frames tend to be those 
who have been HIV positive for a shorter period, have lower viral 
load, higher CD4 counts, and have not had an AIDS defining illness.
Figure 6 – Time frame for future planning 
RElAtIOnSHIPS AnD SEX 
In this section we discuss a range of issues to do with the sexual lives 
and intimate relationships of PLHIV. While there is some attention 
paid to sexual practice, our intention is not to characterise PLHIV 
as a group posing a risk of HIV infection to HIV negative people. To 
this end, we have taken care to characterise the HIV risk reduction 
strategies employed by HIV positive people in sexual relations. 
We have also attempted to address other aspects of sex and 
relationships that are all too often absent from the literature in this 
area. This includes issues of sexual pleasure, the establishment of 
relationships and the consequences of community stigma for both 
sexual lives and other intimate relationships.
Relationships 
Respondents were asked about current sexual relationships. The 
results are presented in Table 37 below. Over one quarter of the 
sample said that they had no sex at present. 
A similar though smaller proportion reported that they had a regular 
relationship only, while slightly more said that they had casual sex 
only, and slightly fewer that they had a regular relationship plus 
casual sex. When this item is broken down by sex and sexuality, we 
find significantly different patterns between three groups of PLHIV. 
Heterosexual men were more likely than other PLHIV to report that 
they had no sex at present. 
Table 37 – Type of sexual relationship(s) by gender  
and sexuality of respondent (percentage)
Attitudes to HIV status Gay or  
Bisexual 
men
Hetero 
-sexual 
men
Women Total
I have no sex at present 26.8 49.9 38.1 28.8
I have casual sex only 36.6 6.7 6.7 32.7
I have a regular 
relationship with one 
person, and I have sex 
with other people
17.5 0.0 4.8 15.4
I have a regular 
relationship with one 
person, and I do not have 
sex with other people
16.1 43.4 48.8 20.0
I have a regular 
relationship with two or 
more people
3.1 0.0 1.6 3.1
Women were more likely to report that they had one regular sexual 
partner and no casual sex. Gay and bisexual men are more likely to 
report that they had a regular sexual partner and also had casual sex. 
When asked if they were currently in a regular relationship, around 
two fifths (41.7%) said they were. This is slightly higher than the 
proportion of the sample that report having sex with a regular 
partner in Table 37 above (38.6%), as some in a regular relationship 
did not have sex. 
10 or more years  
into the future
5 years into  
the future
1 year ahead
A few months 
ahead
One day at a time
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Regular partners 
Of those in a relationship with a regular partner, 40.6 % reported that 
their partner was also HIV positive (generally described as a sero-
concordant relationship). The remainder were in serononconcordant 
relationships. This remaining group is made up of 57.7% of those 
in relationships that report that their partner is HIV negative (a 
serodiscordant relationship) and 1.6% who report that they don’t 
know their partner’s HIV status. Nearly all PLHIV (97.5 %) had told 
their regular partner that they were HIV positive. 
We have reported the data in the following tables on sexual practice 
and condom use in numbers rather than percentages, as the small 
sub-samples would give an inflated view of the proportions in some 
categories. PLHIV in regular relationships were asked about the sex 
they had with their regular partner. Overall, 28.3% of the total sample 
had anal or vaginal sex with a regular male partner in the six months 
prior to completing the survey and 3.2% had anal or vaginal sex with 
a regular female partner in the previous six months. Condom use 
with regular partners can be seen in Table 38 below.
Table 38 – Condom use in penetrative sex with regular partner by 
respondent and partner gender
Number of these 
that used condom 
(N=322) 
Never Sometimes Usually Always
Female respondents N=49
With regular male 
partner
17 6 3 15
Male respondents N=273
With regular male 
partner
132 39 19 64
With regular 
female partner
10 6 3 9
If we look at these data in terms of relationship sero-concordance, 
considerable clarity is given to the patterns of condom use.Unprotected 
vaginal or anal intercourse is more likely to have occurred in sero-
concordant relationships than in sero-nonconcordant relationships.
Table 39 – Condom use with regular partner by respondents’ gender, 
partners’ gender, and partners’ sero-status
Number of these 
that used condom 
Never Sometimes Usually Always
SERO-CONCORDANT Relationships
Female respondents
With regular male 
partner
7 2 3 0
Male respondents
With regular male 
partner
85 7 2 2
With regular 
female partner
5 0 1 1
Number of these 
that used condom 
Never Sometimes Usually Always
SERO-NONCONCORDANT Relationships
Female respondents
With regular male 
partner
4 4 3 9
Male respondents
With regular male 
partner
30 23 13 49
With regular 
female partner
3 4 8 17
Casual partners 
Almost half (48.2%) of the sample reported that in the six months 
prior to completing the survey they had had sex with one or more 
casual partners. When asked the HIV status of their casual partners, 
11.8% reported that all of their casual partners were HIV positive, 51.1% 
reported that some of their casual partners were HIV positive, and 
6.1% reported that none of their casual partners were HIV positive. 
Many (30.9%) of the respondents who had had casual sex reported 
that they did not know the HIV status of their casual partners. 
Respondents were asked about their condom use during anal or 
vaginal intercourse with casual partners over the previous six months.
Table 40 – Condom use with casual partner  
by respondent and partner gender
Number of these 
that used condoms 
Never Sometimes Usually Always
Female respondents
With regular male 
partner
2 1 2 4
Male respondents
With regular male 
partner
78 160 86 113
With regular 
female partner
2 0 0 3
As can be seen from Table 40 there are considerable variations in 
condom use when we examine this by sex of respondent and sex of 
partner. Again, when we look at these data in terms of the partners’ 
HIV status, a clearer pattern emerges (see Table 41). 
Table 41 – Condom use with male casual partner  
by partners’ sero-status
Number of these 
that used condoms 
Never Sometimes Usually Always
Casual partners’ HIV Status
All HIV positive 36 11 3 3
Mixture/unsure 27 118 60 41
All HIV negative 3 2 3 15
There is a significant relationship between condom use and partners’ 
HIV status: consistent unprotected anal and vaginal intercourse 
occurs primarily with HIV positive partners, whereas with HIV 
negative partners or those of unknown status, condom use was much 
more likely. 
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In addition to reporting on their overall patterns of condom use, 
respondents who had had casual sex reported on their most recent 
sexual encounter with a casual partner. Almost half the survey 
(47.8%) respondents provided such information. Of the respondents 
who had casual sex, 77.2% had vaginal or anal intercourse on their 
last occasion with a casual partner. 
As was found for the overall patterns of condom use, condom use 
during respondents’ most recent sexual encounter was contingent 
on the HIV status of the partner. Figure 7 gives a breakdown of the 
range of protective strategies employed by positive people to protect 
their most recent casual partner. 
This includes knowledge of HIV status, condom use and avoidance 
of ejaculation within their partner. This schematic shows that for the 
entire set of data available, incidents that involved any risk were very 
rare and mostly associated with partners of unknown status. 
YES
61
39.3%
YES
65
41.9%
Sex with a casual partner in the last six months?
HIV status of casual partner (missing=2)
Condom used? (missing=8)
Ejaculated in partner? (male respondents only) 
Ejaculated in by partner? 
nO
501
47.8%
nO
114
22.8%
HIV POSItIVE
174
45.2%
HIV nEGAtIVE
64
16.8%
YES
546
52.2%
YES
386
77.2%
StAtUS UnknOwn
146
38.1%
YES
85
60.8%
nO
45
85.5%
nO
31
57.2%
Figure 7 – Sexual practice with the most recent casual partner
nO
55
39.2%
YES
8
14.5%
YES
24
42.8%
nO
156
90.3%
nO
94
60.7%
nO
90
58.1%
YES
45
71.2%
nO
11
66.2%
nO
9
47.3%
nO
18
28.8%
YES
6
33.8%
YES
10
52.7%
YES
17
9.7%
Anal/vaginal intercourse with the casual partner? (missing=46)
tHE SOCIAl wORlD Of PlHIV
HIV Futures Seven – The Health and Wellbeing of HIV Positive People in Australia, ARCSHS 2013 20
 
HIV, sex, relationships and treatments
PLHIV were asked to respond to a number of statements about 
relationships, sex and HIV. The results of these items are shown in full 
in Table 42. 
When asked whether they would prefer to be in a relationship with 
someone who is also HIV positive, around half (53.7%) said they 
would, a third (32.2%) said they would not, and the remainder (14.1%) 
said that they did not know. 
The potential to develop new relationships remains an important 
issue for PLHIV. While much has been done to reduce stigma and 
discrimination in formal settings such as workplaces and healthcare 
settings, the more intimate domains of sex and relationships can 
still be a site of anxiety and uncertainty for both HIV positive and 
negative people. 
Over two thirds (68.8%) of the respondents agreed with the 
statement Few people would want a relationship with someone who 
has HIV. A similar response was found to the statement I am afraid of 
telling potential partners of my HIV status in case they reject me. Over 
half the respondents (60.0%) agreed with this statement. 
Concerns about transmission of the virus to others and re-infection 
were apparent in the responses to the next six items. Most 
respondents (66.2%) agreed with the statement I am afraid of 
infecting my partner, or potential partner, with HIV, while very few 
agreed with the statements I feel more confident about unprotected 
sex because of the new treatments; Withdrawing before ejaculating 
(cumming) is a way to reduce the risk of passing on HIV; and 
Undetectable viral load means HIV is unlikely to be transmitted to a 
sexual partner even if I have sex without a condom. Greater concern 
on these items was expressed by those with HIV negative regular 
partners, those having only casual partners and those not currently 
having sex. 
The response to concerns about re-infection remains mixed, with 
44.0% agreeing that I am concerned about becoming infected with 
another strain of HIV and 46.2% disagreeing. 
When we examine the impact of HIV on sexual pleasure, we find that 
the majority of the respondents (61.7%) agreed with the statement 
HIV has had a negative effect on my sexual pleasure. One third 
(33.8%) disagreed with this statement. 
When asked about the relationship between partners’ HIV status and 
sexual pleasure here was a greater degree of uncertainty. 18.6% were 
unsure when asked to respond to the statement If I know that my 
partner is HIV positive I find sex more pleasurable. More respondents 
agreed with this statement (54.2%) than disagreed with it (29.0%). 
Over one quarter (38.2%) said that they agreed with the statement I 
have stopped having sex because of my HIV status. Similarly, 57.6% of 
participants agreed that HIV has negatively affected my libido.
Table 42 – Attitudes to HIV, sex and relationships
Attitudes to HIV, sex and relationships Strongly 
disagree 
Disagree Agree Strongly 
agree
Don’t 
know
I prefer to have a relationship with someone who also has HIV 9.3 22.9 28.9 24.8 14.1
Few people would want a relationship with someone who has HIV 6.0 19.0 41.3 27.5 6.2
I am afraid of telling potential partners of my HIV status in case they reject me 12.1 19.9 34.3 25.7 8.0
Being HIV positive has helped me form more satisfying relationships 24.3 37.9 17.7 5.9 14.2
I am afraid of infecting my partner, or potential partner, with HIV 9.4 20.5 34.7 31.5 3.8
I feel more confident about unprotected sex because of the new treatments 34.5 35.8 18.7 4.1 7.0
Medical treatments for HIV/AIDS make safe sex less important than it was 39.9 35.4 14.9 4.2 5.6
Withdrawing before ejaculating (cumming) is a way to reduce the risk of passing on HIV 38.3 33.0 19.6 3.3 5.9
Undetectable viral load means HIV is unlikely to be transmitted to a sexual partner 
even if I have sex without a condom
29.5 34.9 23.4 4.7 7.5
I am concerned about becoming infected with another strain of HIV 16.2 30.0 29.7 14.3 9.7
HIV has had a negative effect on my sexual pleasure 11.9 21.9 32.9 28.8 4.5
If I know that my partner is HIV positive I find sex more pleasurable 10.6 18.4 29.1 25.1 16.8
I stopped having sex because of my HIV status 23.6 35.3 24.0 14.2 2.8
HIV has negatively affected my libido 15.5 22.1 33.2 24.4 4.8
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Criminalisation of HIV transmission
Recent high-profile cases of criminal prosecution for HIV transmission 
in Australia and internationally have changed the landscape within 
which HIV positive people assess their HIV status and make decisions 
about how and when to disclose their status. In this year’s survey we 
included questions to assess the impact of these developments on 
the experiences of PLHIV.
These cases and their ensuing media coverage, as well as an increase 
in the number of criminal prosecutions for transmitting HIV (Groves 
and Cameron, 2009), have intensified the discussion about the 
criminalisation of HIV transmission. A recently published NAPWA 
monograph explores these issues in depth (see NAPWA, 2009). 
Research has shown that dominant views about criminal prosecution 
of HIV undermines HIV prevention efforts by placing expectation of 
responsibility solely on the HIV positive sexual partner (Dodds, 2008) 
and has the potential to reinforce stigma of HIV/AIDS (UNAIDS, 2008). 
In 2008, the Department of Health and Ageing produced the 
National Guidelines for the Management of People with HIV who 
Place Others at Risk (Dodds, 2008), developed by the Blood 
Borne Virus and Sexually Transmissible Infections Sub-Committee 
(BBVSS) of the Australian Population Health Development Principal 
Committee (APHDPC). 
The Guidelines’ stated aim is to inform and standardise approaches 
in the various states and territories to the small number of people 
for whom coercive measures are needed. It acknowledges that an 
individual has the responsibility of protecting themselves and others 
from infection and that in most cases of potential transmission, 
prevention is best achieved through information, education, and the 
provision of resources. The Guidelines recommend that the roles of 
clinician and public health official be kept distinct.
In an AFAO discussion paper, Groves and Cameron (2009) note that 
the intersection of public health with criminal law is fraught, and the 
authors highlight the need for discussion about the way in which 
justice and health agencies can work together effectively. 
They recommend further research on the effects on affected 
communities and point out the need for developing ways to work 
with journalists to ensure sensitive and accurate reporting of criminal 
prosecution. They also point to the need to address potential 
“fallout” issues such as re-establishing trust with doctors.
Table 43 – Attitudes toward legal issues
Attitudes to HIV, sex  
and relationships
Strongly 
disagree 
Disagree Agree Strongly 
agree
Don’t 
know
I am worried about 
disclosing my HIV 
status to sexual 
partners because 
of the current legal 
situation
16.3 27.6 25.6 19.6 10.9
I am worried 
about disclosing 
my sexual 
practice to service 
providers because 
of the current 
legal situation
21.0 36.2 17.3 12.8 12.7
In the survey, we asked participants to what extent the current legal 
situation has had an impact on their decisions to disclose their status 
to sexual partners and their sexual practices to service providers. 
Clearly legal issues are important to people, with 45.2% agreeing with 
the statement I am worried about disclosing my HIV status to sexual 
partners because of the current legal situation. 
There was less concern about the legal implications of disclosure of 
sexual practices to service providers, however 30.1% expressed some 
concern and 12.7% were uncertain. 
CHIlDREn 
18.7% of those surveyed currently have children and 6.4% have 
dependent children. We were also interested in future plans for 
children among PLHIV. Most PLHIV (73.4%) were not currently 
considering having children. 
Of the remainder, 21 PLHIV had decided to have children in the future 
and 1 is attempting to have children. 42 were considering having a 
child, but have not decided, and 21 people have considered having 
a child, but have decided it is too risky. Three respondents were 
pregnant. While a greater proportion of women (heterosexual, bisexual 
and lesbian) were considering, or had considered having children, 
some of those doing so are gay, bisexual or heterosexual men.
Table 44 – Planning to have children (number)
Gay or 
Bisexual 
Men
Hetero 
-sexual 
Men
Women Total
No 673 23 29 773
No, I already have 
children
47 14 38 105
I have decided to 
have a child/children 
in the future
13 2 4 21
I am currently 
trying to conceive/
get pregnant
- 1 3 1
I am currently 
pregnant
- - 8 3
I have thought 
about it but I 
haven’t decided
31 - 2 42
I have thought 
about it but I have 
decided that it is 
too risky
17 1 1 21
I don’t have 
enough information  
to make a decision
2 - - 4
Other 28 3 5 29
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RECREAtIOnAl DRUG USE 
Practices 
Respondents were asked about their use of a range of non-
prescription drugs, both those legally available and those that are 
currently prohibited in Australia. 
Respondents were asked which of a list of substances they had used 
in the last twelve months. For those drugs which are commonly 
injected, differentiation was made between injection and other 
means of administration. 
Table 45 gives these results. As can be seen from these data, alcohol 
was the most commonly used drug followed by tobacco. Other drugs 
that are popular in the gay and dance party scenes (amyl, ecstasy, 
non-injected speed and LSD) were also used by PLHIV. 
Table 45 – Recreational use of drugs (percentage of sample)
Drugs Percent
Alcohol 79.5
Tobacco 30.2
Marijuana 35.9
Amyl 34.1
Ecstasy 13.6
Viagra or similar 27.7
Crystal Meth 16.5
Speed (not injected) 5.5
Speed (injected) 4.5
Cocaine (not injected) 7.1
GHB/GBH/Fantasy 7.1
LSD/trips 3.4
Steroids (injected) 1.6
Heroin (injected) 1.9
Methadone (prescribed) 1.4
Other 3.3
(Multiple responses possible) 
In addition we asked people the amount of alcohol they consumed: 
of those who drank, 47.4% drank less than once per week, 28.5% 
drank weekly and 24.0% drank daily. Similarly, with marijuana, 36.8% 
smoked less than once a week, 14.7% weekly and 28.4% daily. 
It must be noted that we only asked respondents if they had used 
each of the other drugs in the previous twelve months, not how often 
they use them. Use of many drugs is occasional rather than regular 
and this may inflate the rates reported here. Gay male respondents 
were significantly more likely than other groups to have used alcohol, 
ecstasy, amyl and crystal-meth and less likely to have used heroin 
(injected) and prescribed methadone. 
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ACCOMMODAtIOn 
We asked a series of questions about participants’ accommodation 
status and experiences. These experiences vary considerably among 
PLHIV, most particularly as a function of whether individuals are in 
private or public accommodation. 
Current accommodation 
The current type of accommodation of the respondents can be seen 
in Table 46. Similar numbers of PLHIV were in accommodation that 
they own or rent through the private system. A smaller number of 
people were in public rental accommodation. These were more likely 
to be those on a government benefit. 
Table 46 – Current accommodation of respondents  
(percentage of total sample)
Accommodation Percent
Own or purchasing house or flat 41.5
Private rental accommodation 34.1
Public rental accommodation(government owned) 12.8
Rent-free (e.g. provided by friends, family, etc.) 4.8
Community housing/housing co-operative 3.8
Other 3.1
Households varied considerably. 41.2% of PLHIV lived by themselves, 
while the remainder lived with between 1 and 8 other adults 
(median=1) and with between 1 and 4 children (for those living with 
children: mode=1 median=1). Around one third (31.9%) lived with a 
partner or spouse, and 5.7% lived with dependent children. In addition, 
6.6% lived with other family members and 17.0% with a flatmate. 
49.2% of PLHIV also lived with pets. The most common pets were 
dogs and cats. Other companion animals included fish, birds, rabbits 
and farm animals. 76.1% of respondents had access to a car. When 
asked how easy it was to access public transportation, 12.5% said it 
was very difficult, 13.3%, difficult, 36.1%, easy and 38.0%, very easy. 
EMPlOYMEnt 
The area of employment continues to present challenges to HIV 
positive people. 
While the need for financial security, social contact and a sense of 
worth are critical factors in HIV positive people’s wishes to be in paid 
employment, the management of HIV disclosure, the intermittent 
effects of illness and the need for flexibility around taking time off can 
prove substantial barriers to obtaining and retaining employment. 
There are also considerable obstacles for those who have left 
employment in the past and are attempting to return to the workforce. 
These include de-skilling, explaining an extended absence for the 
workforce, issues of aging and changes in life goals. 
Employment status 
Just over half (58.2%) of the respondents were currently employed, 
with more being in full-time work (38.5%) than those in part-time 
work (19.7%). The remainder tended to describe themselves as either 
not working/home duties/retired (19.7%) or unemployed (10.6%). 
11.9% said their work was HIV-related. 
Of those who were working, the mean number of hours worked 
was 37.8 per week (median=38.0). Those working full time worked 
an average of 43.5 hours per week (median=40.0) and those in 
part time employment worked an average of 22.6 hours/week 
(median=22.2). 
Table 47 – Employment status
Employment Percent
Work full-time 38.5
Not working/Retired /Home duties 19.7
Work part-time 14.7
Unemployed 10.6
Student 4.6
Other 11.8
Impact of HIV on employment 
We asked respondents how their initial HIV diagnosis affected their 
career plans. These data are shown in Table 48 below. A large proportion 
indicated that their career ended at their time of diagnosis (16.4%). 
Table 48 – Impact of HIV diagnosis on career plans  
(percentage of sample)
Impact Percent
My career plans did not change 31.6
It was more difficult to plan for the future 24.3
My career ended/I stopped work 16.4
A career was no longer as important 13.7
I changed careers 9.9
I was less likely to change careers 4.0
Those currently in paid employment 
Respondents were asked about the level of stress in their current job. 
Two fifths rated the stress level as moderate (40.7%) while 29.4% said 
it was high and 9.0% said it was very high. Only 5.7% rated the stress 
level as very low and 15.2% said there was low stress (see Figure 8). 
Those in full-time work were somewhat more likely to report stress. 
Figure 8 – Stress at work
Home, work and money
0% 10% 20% 30% 40% 50% 60%
Part time
Full time
Total
Very low Very highLow Moderate High
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Confidentiality in the workplace remains a critical and complex 
issue for positive people, particularly given ongoing experiences of 
discrimination. When asked what difficulties they experience around 
confidentiality at work, 16.1% said that they did not attempt to keep 
their status confidential (see Table 49). 
63.6% said they have experienced no problem in this area. Of those 
who did experience difficulties, the greatest problem appeared to be 
gossip, followed by issues around explaining absences from work, 
and medication. 
When we examine the difficulties associated with confidentiality in terms 
of whether the respondent works in an HIV related job, we find that those 
in HIV related employment were less likely to wish to keep their status 
confidential and had fewer problems when they do chose to do so. 
Table 49 – Difficulties with HIV status confidentiality in the 
workplace: percentages of total and specific samples
Difficulties Total 
working 
sample 
AIDS 
related
Non-AIDS 
related
No problems 63.6 36.9 70.2
I do not try to keep my HIV 
status confidential
16.1 57.8 10.4
Gossip 7.2 4.1 8.0
Explaining absences from work 11.2 2.8 12.9
Visible signs of illness 7.7 4.7 8.5
Difficulty keeping and taking 
medication
3.4 1.9 3.8
Other 3.3 1.5 3.7
(Multiple responses possible) 
When asked how many people in their workplace knew that they 
were HIV positive, 9.7% said that everyone knew, 7.8% said most 
people knew, 17.6% said a few people knew, 14.6% said one person 
knew and 54.6% said no-one knew (see Figure 9).
Those working in a HIV related job were more likely to say everyone 
knew their HIV status than those in non- HIV related work (42.1% 
versus 2.5%) and similarly less likely to say no-one knew their HIV 
status (12.4% versus 61.0%). 
Figure 9 – Disclosure in workplace
When asked about the impact that HIV had on their capacity to 
perform their work duties, over half of the sample said that their 
work was unaffected (see Table 50). One third said that they tired 
more quickly, and one fifth said that they had difficulty concentrating. 
Table 50 – Impact of HIV on work capacity (percentage of those in 
paid employment)
Impact Percent
It is not affected 53.9
I tire more quickly 35.2
I have difficulty concentrating 16.6
I am less productive 11.2
I cannot always go to work 10.3
I work reduced hours 9.7
I do different duties 2.0
Other 3.9
(Multiple responses possible) 
Living with HIV often involves intermittent periods of ill health, 
particularly around treatment changes and the need to access health 
and other services, often only available during work hours (Prestage 
et al. 2001). Respondents were asked how much flexibility their 
workplace gives them to take time off for reasons relating to HIV. 
Most PLHIV had the capacity to take time off for medical 
appointments (see Table 51 below) and illness. There was less 
capacity to take time off for counselling and few had much capacity 
to take time off to engage in volunteer work. 
Table 51 – Capacity within workplace for HIV related interruptions  
(percentage of those in paid employment)
Capacity Never Seldom Sometimes Often Always
For medical 
appointments
7.3 4.2 17.2 15.0 56.3
For counselling 22.0 9.1 19.0 9.7 40.1
When you are sick 3.7 3.6 15.0 13.3 64.4
To do volunteer 
work
43.7 10.1 16.6 4.8 24.9
HOME, wORk AnD MOnEY
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fInAnCES 
The HIV Futures surveys have highlighted the financial difficulties 
that many PLHIV contend with. These difficulties cannot be explained 
simply by the proportion of PLHIV relying on government pensions 
or benefits. There are financial hardships associated with being HIV 
positive. Some of these are structural and systemic, for example 
the costs associated with managing the negative consequences of 
treatment, some result from stigma and disadvantage that result 
from reduced employment options, while others are the cumulative 
effects of living for many years with uncertain or fluctuating health 
and well being. 
Income 
The source of income of the survey respondents is shown in Table 
52 below. As with the previous HIV Futures survey, there were more 
people receiving a salary (47.1%) than on a government benefit 
(38.1%), suggesting an encouraging trend.
Table 52 – Primary source of income: percentage of total sample
Income Percent
Salary 47.1
Benefits/pension/social security 38.1
Superannuation/annuity/savings 5.7
Other 5.7
Partner supports me 2.9
Family/friends support me 0.6
The median weekly in-hand income for respondents was $541 
and $662 excluding those reporting zero income. Figure 10 below 
gives the distribution of income in $125 intervals. The peak of the 
distribution corresponds to the income that one is likely to receive 
on a government pension. 23.5% of respondents had a partner with 
whom they share financial resources. The partners’ median weekly 
income was $800. 
Expenditure and debts 
Respondents were asked their weekly expenditure on a range of 
items. The results are shown in Table 53 below. The total mean 
expenditure on medication was $74 per week. Mean rental or 
mortgage costs were $323. Food and utilities accounted for around 
$130 and $77 respectively. 21.7% of respondents owned their own 
home, while 22.2% were paying off their home. 25.0% received 
a rental subsidy averaging at $168.9per week (median= $70). 
Respondents were also asked their current debt burden as one 
measure of the financial impact of HIV. This averaged at $33,000 with 
a median of $100. 
Table 53 – Weekly expenditure on medications and essentials ($AU)
Expenditure Mean Median
Rent or mortgage repayments $323 $250
Food $130 $100
Utilities $77 $60
Complementary therapies $35 $20
Other medication $22 $11
Antiretroviral drugs $17 $10
Assessments of benefits 
People receiving a pension may undergo an assessment by a 
Commonwealth Medical Officer. As there has been considerable 
community discussion about the impact of these assessments we 
asked respondents about their experiences. A total of 26.6% (n=231) 
of those receiving a benefit in the previous two years had received 
such an assessment. 
When asked what this experience resulted in, only 6.9% (n=16) said 
that their benefit was terminated (See Table 54 next page). 23.4% 
said that the assessment resulted in changes to their conditions of 
benefit. Importantly the experience of assessment resulted in distress 
for two fifths of the respondents while it clarified concerns for around 
one in ten. 
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Figure 10 – Histogram of respondents’weekly income after tax
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Table 54 – Consequences of receiving an assessment of benefit  
from a Commonwealth Medical Officer  
(percentage of those assessed in last 2 years)
Consequences Percent
Require documentation from your doctor 56.2
Cause you distress 58.9
Result in changes to the conditions of your benefits 23.4
Result in an independent assessment 16.1
Clarify concerns that you had 11.6
Result in a shift from Pension to Newstart allowance 6.8
Result in termination of your benefits 6.9
(Multiple responses possible) 
POVERtY 
As with the previous HIV Futures surveys, we have used the quarterly 
Henderson Poverty Lines published by the Melbourne Institute of 
Applied Economics and Social Research to assess the extent of 
poverty among PLHIV. The Henderson Poverty lines are set for 
specific income units. These units include the individual, any partner 
with whom they share financial resources and any dependent 
children. We used the Institute’s data for the December 2011 quarter 
(Melbourne Institute of Applied Economic and Social Research, 2012), 
the time at which the survey was completed. 
According to this measure over one quarter (28.6%) of PLHIV were 
living below the poverty line. That this figure has remained so high 
across the ten years of the HIV Futures surveys suggests that current 
resources and strategies are inadequate and decisive action must be 
taken to address this pocket of severe social disadvantage. 
Correlates of poverty 
We look now at the differences between different groups in their 
likelihood to be living in poverty. Those in paid employment were 
significantly less likely to be classified as below the poverty line. 
Two fifths of those not in paid employment were living in poverty 
(see Table 55). 
Table 55 – Poverty by employment status  
(percentage of employment categories)
Employment status Below 
poverty 
line 
Above 
poverty  
line
Employed 11.7 88.3
Not employed 44.4 55.6
χ 2 (1,1) = 138.190, p<0.001 
Respondents who identified a salary as their primary source of 
income were significantly less likely to report an income below the 
poverty line. Over half of those on a government benefit were living 
in poverty (see Table 56). 
There was no gender difference in the proportions of people living 
below the poverty line. 
Table 56 – Poverty by income source
Income type Below 
poverty 
line 
Above 
poverty  
line
Salary 8.9 91.1
Super/annuity/savings 22.4 77.6
Partner/ Family/friends/ Other 33.0 67.0
Benefits/pension/social security 48.7 51.3
χ 2 (3,1) = 175.372, p<0.001 
There is also a clear relationship between poverty and self-rated 
health and well being (see Table 57 and Table 58). Those living 
below the poverty line were significantly more likely to rate these 
characteristics as poor or fair. 
This pattern most likely represents an interaction between poverty 
and these factors, rather than a directional relationship. Worse health 
and well being limit access to employment and financial security, 
while poverty creates emotional distress, limits social interaction and 
damages health. 
Table 57 – Self-rated health of those above and below the poverty 
line (percent within poverty group)
Self-rated health Below 
poverty 
line 
Above 
poverty  
line
Poor 47.2 52.8
Fair 36.0 64.0
Good 25.9 74.1
Excellent 20.2 79.8
χ 2 (3,1) =29.531, p<0.001
Table 58 – Self-rated well being of those above and below  
the poverty line (percent within poverty group)
Self-rated health Below 
poverty 
line 
Above 
poverty  
line
Poor 46.6 53.4
Fair 36.5 63.5
Good 24.4 75.6
Excellent 15.4 84.6
χ 2 (3,1) = 47.440, p<0.001 
HOME, wORk AnD MOnEY
HIV Futures Seven – The Health and Wellbeing of HIV Positive People in Australia, ARCSHS 201327
 
Costs 
As with previous surveys, we asked respondents about the difficulty 
they had paying for a range of activities, goods and services. 
The results are shown in Table 59 below, with the not applicable 
responses excluded from the calculation for each item. 
The items that most respondents rated as very difficult to pay for 
were quality of life costs like travel, going out, recreational drugs 
and entertainment. Those items most likely to be rated as not at all 
difficult were support services, medical services and medication. 
Importantly substantial proportions rated food, clothing, utilities 
and rent as very difficult. The experience of difficulty in meeting the 
costs of these items was rarely restricted to one area. That is, when 
individuals had difficulty paying for food, they also experienced 
difficulties with rent, utilities and quality of life items. 
When we examine the ratings of these items for those above and 
below the poverty line, those living in poverty were more likely to 
rate all items as very difficult (see Table 60 on next page). 
Disturbingly, among those living below the poverty line, one 
quarter rated paying for medical services as very difficult, while the 
proportions that gave this response for co-payments for medication 
and costs of other prescribed medication are also very concerning. 
When it comes to the basics of life, substantial numbers of those 
below the poverty line also rated these as very difficult.
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Table 59 – Difficulty paying costs of items and services
Difficulty paying costs Not at all 
difficult
A little  
difficult
Very  
difficult
Co-payments for medication for HIV/AIDS (n=724)3 63.7 26.8 9.5
Other prescribed medication (n=872) 56.2 34.1 9.7
Medical services (doctor, dentist, etc.) (n=891) 56.1 28.4 15.5
Complementary Therapies (n=614) 52.4 26.9 20.7
Support services (counselling, etc.) (n=491) 67.5 17.6 14.9
Entertainment (theatre, movies, concerts, etc.) (n=875) 38.3 29.0 32.7
Going out (eating/drinking) (n=911) 33.9 33.0 33.1
Sport (exerrcise, gym, etc.) (n=688) 44.8 29.0 26.2
Recreational drugs (n=377) 40.1 26.6 33.2
Travel/holidays (n=844) 27 26.6 46.4
Rent/Mortgage/Housing costs (n=873) 40.6 39.0 20.3
Utilities (telephone/electricity/gas/water) (n=971) 39.6 36.7 23.7
Food (n=980) 47.9 35.0 17.1
Clothing (n=948) 40.2 30.4 29.4
Transport (n=924) 47.7 33.5 18.8
Child care (n=77) 69.8 7.2 23
3  Ns refer to the number of participants that identified this as an applicable cost.  
That is, those selecting 'not applicable' or giving no response are excluded from  
the percentages reported in that row.
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DISCRIMInAtIOn
Discrimination on the basis of HIV is unlawful in all jurisdictions in 
Australia. The introduction of anti-discrimination legislation has 
offered an avenue of redress for those with the energy and courage 
to pursue it, acts as a deterrent for employers, service providers 
and the like, and sends a clear message that such discrimination is 
unacceptable to the Australian population. 
However, PLHIV continue to experience less favourable treatment in 
many domains of their lives. While more detailed research is needed 
to adequately assess the specific impact of this treatment, we can 
reasonably imagine that the impact goes beyond the direct outcomes 
of the actions and is detrimental to both health and quality of life. 
In addition the anticipation of discrimination may limit people’s 
life choices in subtle but sustained ways. We have asked about the 
experience of discrimination in a range of settings. 
Accommodation 
7.4% of respondents indicated that they had experienced less favourable 
treatment in relation to accommodation (2.8% in the last two years). 
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Table 60 Difficulty paying costs of items and services by poverty status
Difficulty paying costs Below poverty line Above poverty line
Not at all 
difficult
A little  
difficult
Very  
difficult
Not at all 
difficult
A little  
difficult
Very  
difficult
Co-payments for medication for HIV/AIDS 
(n=193, 531)4
53.4 32.4 14.2 67.5 24.7 7.8
Other prescribed medication (n=230, 641) 42.0 43.2 14.9 61.3 30.8 7.9
Medical services (doctor, dentist, etc.) 
(n=227, 664)
46.3 26.3 27.4 59.4 29.2 11.4
Complementary Therapies (n=150, 464) 33.6 29.6 36.7 58.4 26.0 15.6
Support services (counselling, etc.) (n=127, 364) 59.7 20.8 19.5 70.3 16.5 13.3
Entertainment (theatre, movies, concerts, 
etc.) (n=227, 648)
18.7 27.7 53.6 45.2 29.5 25.3
Going out (eating/drinking) (n=230, 681) 14.0 28.7 57.2 40.6 34.5 24.9
Sport (exercise, gym, etc.) (n=170, 518) 22.8 31.5 45.7 52.1 28.1 19.8
Recreational drugs (n=107, 269) 22.5 21.5 56.0 47.1 28.7 24.2
Travel/holidays (n=211, 633) 10.7 21.1 68.1 32.4 28.5 39.1
Rent/Mortgage/Housing costs (n=219, 654) 27 44.5 28.5 45.2 37.2 17.6
Utilities (telephone/electricity/gas/water) 
(n=254, 717)
22.7 40.1 37.2 45.6 35.5 18.9
Food (n=262, 718) 27.5 46.5 26.0 55.3 30.8 13.9
Clothing (n=248, 701) 22.2 36.1 41.7 46.6 28.3 25.1
Transport (n=239, 686) 27.4 40.9 31.7 54.8 30.9 14.3
Child care (n=14, 63) 69.3 8.9 21.8 69.9 6.9 23.3
4 Ns refer to the number of participants below and above the poverty line respectively that 
identified this as an applicable cost. That is, those selecting 'not applicable' or giving no 
response are excluded from the percentages reported in that row.
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Health services 
27.6% of respondents had experienced less-favourable treatment at a 
medical service as a result of having HIV. This comprised 13.0% of all 
respondents that had experienced such discrimination in the last two 
years and 14.6% that experienced this more than 2 years ago.
When asked what form this discrimination took, the most common 
responses were avoidance (43.5%) confidentiality problems (38.7%) 
and increased infection control (39.1%). These experiences are shown 
in Table 61. 
Table 61 – Form of HIV-related discrimination experienced at medical 
service (percentage of those experiencing discrimination)
HIV-related discrimination Ever 
(N=284) 
In last 
2 years 
(N=133)
Avoidance 43.5 42.8
Confidentiality problems 38.7 41.7
Increased infection control 39.1 31.4
Refusal of treatment 23.9 21.0
Treated last 33.8 30.2
Rushed through 29.2 32.2
Harassment 15.6 17.4
Abuse 10.6 10.0
(Multiple responses possible) 
Insurance 
38.7 % of respondents currently had private health insurance and 15.6 
% currently had some other form of income or mortgage insurance. 
23.4 % of respondents indicated that they had experienced less 
favourable treatment in relation to insurance. The most commonly 
reported example of less favourable treatment was being unable to 
take out an insurance policy, for example health insurance and travel 
insurance. 
Workplace 
15.4% of respondents had experienced less-favourable treatment in 
the workplace as a result of having HIV. This comprised 4.8% of all 
respondents that had experienced such discrimination in the last two 
years and 10.6% that experienced this more than 2 years ago. When 
asked what form this discrimination took the comments ranged from 
unfair dismissal to reduced advancement opportunities to bullying. 
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MEtHODS AnD InStRUMEnt 
This section describes the research design, method of recruitment, 
development of the survey instrument, sampling issues and data 
analysis. 
The survey instrument 
HIV Futures is an anonymous, cross-sectional survey of a sample of 
people living with HV/AIDS in Australia. The HIV Futures 7 survey ran 
from October 2011 through April 2012. The survey was available as 
both a self-complete mail back survey and on-line. This is the second 
time that HIV Futures has been made available on-line, reflecting the 
growing use of the internet amongst Australian households. 
On-line surveys have been used successfully to collect health 
information from GLBTI Australians and same sex attracted young 
people in Australia (Hillier et al., 2005, Pitts et al., 2006). We hoped 
that by offering HIV Futures online we would provide an easier way 
for the usual demographic of respondents to complete the survey 
and also allow us to access harder to reach PLHIV, such as those 
living in rural or regional areas, or those not in contact with HIV/
AIDS services. The on-line survey was accessed through the website 
www.HIVfutures.org.au. The site was hosted by Demographix.co.uk, 
an experienced commercial provider of web-based surveys with 
excellent attention to issues of security and privacy. 
Design 
The instrument was based in large part on the HIV Futures 6 survey 
(Grierson et al., 2009), which in turn was adapted from the five 
previous surveys (Ezzy et al., 1998, Grierson et al., 2000, Grierson 
et al., 2004a, Grierson 2006). The survey content was developed in 
consultation with a number of organisations and individuals from the 
HIV/AIDS sector (see Consultations section below). Most items were 
retained in their original format to allow comparisons between the six 
studies. 
New questions and options were added to reflect changes in the 
context in which people live with HIV/AIDS in Australia, including 
policy and service changes over the past three years. Questions 
were also edited, and some removed, to make the survey easier to 
complete.
The survey consisted of 170 items organised into eight sections: 
demographics; accommodation; health and treatments; services 
and communities; sex and relationships; employment; recreational 
drug use; and finances. Each section included an explanation of the 
purpose of the items. Most items in the survey were closed-coded 
with either single or multiple response options. 
‘Other’ categories were included for most items to ensure that 
significant experiences of living with HIV were not excluded. There 
was a number of attitude/ belief items scored using a four- and five-
point Likert scales. There were also write-in and open-ended items. 
The online survey used identical wording to the paper survey 
and contained exactly the same items, however the online survey 
provided users with pull-down menus for some items, such as 
numbers, years and months. These were included in order to ensure 
relatively clean data. The online survey also had a number of skips 
built into it so that respondents did not have to see items that were 
not relevant to them, for example, respondents who were not taking 
antiretroviral treatments did not have to see the questions about 
these treatments. 
Completed paper surveys were returned in a reply-paid envelope 
to La Trobe University. Respondents were also able to add their 
contact details to the program mailing list to receive reports and to 
participate in further research by completing an additional form and 
sending it in a separate envelope. 
On-line surveys were able to be saved and re-opened by respondents 
so that they could be completed in their own time. Completed 
surveys were submitted online and stored by demographix.co.uk. 
Respondents completing the survey online were also able to provide 
researchers with their contact details by filling in and submitting a 
separate form, which was stored in a database separate from the 
survey data. 
RECRUItMEnt AnD SAMPlInG 
There is no register of HIV positive Australians, as HIV testing is 
voluntary and anonymous. As the survey was anonymous and as 
multiple recruitment strategies were employed a simple response 
rate cannot be calculated. Recruitment took place using a set of 
methods in order to reach a diverse population of HIV positive 
Australians. 
This approach meant that some participants received multiple copies 
of the survey from different sources. Recruitment was also combined 
with a promotion strategy that increased community awareness of 
the research and its utility. The inside front cover of the paper survey 
also contained the link to the online survey so that each participant 
receiving a paper copy was also informed about the availability of 
the on-line survey. 
1. Direct distribution 
One copy of the survey was mailed directly to individuals who 
participated in HIV Futures 5 and expressed interest in participating 
in future research conducted by the Living with HIV program at 
ARCSHS. Potential participants were able to request a copy of the 
survey by telephoning the free call number, emailing the researchers. 
2. Promotion and marketing 
Paid Advertising 
The survey was advertised in a number of gay newspapers with 
distribution around the country. Banner ads with a direct link to the 
on-line survey were placed on: gaydar.com.au.
Advertising through community organisations 
The survey was promoted extensively through community 
organisations. Advertisements, articles and news items were placed 
in community newsletters, banner ads were placed on community 
websites and promotional postcards and reception cards were placed 
at reception desks.
3. Community sites 
In addition to advertising the survey, community organisations were 
involved in promoting the study by mailing the survey to members 
accompanied by a covering letter from the organisation explaining 
the purpose of the study, explaining the value of the research, and 
encouraging participation. 
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The survey forms were made available on-site at numerous 
community organisations around the country. These organisations 
also distributed copies of the survey to sites and venues they felt 
were appropriate and with whom they have ongoing relationships. 
Staff at some organisations also assisted people to complete surveys. 
The survey was also promoted at staff and volunteer meetings. 
4. Clinical sites 
a. General Practitioners 
Copies of the survey, postcards and reception cards were mailed 
directly to clinical practices that see a significant number of HIV 
positive clients. This included, but was not limited to, the S100 
prescribers. The survey the web link was also promoted by ASHM 
(Australasian Society for HIV Medicine) to its members and email 
lists. 
b. Hospital settings 
Where ethical approval was obtained, the survey was available in 
the waiting areas of a number of HIV and Infectious Disease clinics 
or distributed directly to clients by staff. Surveys were also available 
through social workers in some hospitals. 
c. Other clinical sites 
Surveys were also distributed through sexual health centres and 
community health centres including those with a specific HIV focus. 
Generally these were available in waiting rooms, although some 
distributed them directly to clients..
JUStIfICAtIOn Of StUDY MEtHODOlOGY 
HIV Futures is a cross-sectional study of a sample of HIV positive 
Australian residents. A cross-sectional study is one in which a new 
sample is collected on each occasion. While a proportion of the 
sample may have completed the previous surveys, the responses 
for each survey are not formally linked, so that direct comparison 
between individuals’ responses over time is not possible. The cross-
sectional methodology was chosen for the following reasons. 
The HIV Futures surveys are anonymous. HIV/AIDS remains a 
sensitive issue for many PLHIV in Australia. Our previous research 
and that of our colleagues tell us that PLHIV still experience stigma 
and discrimination.
Allowing the survey to be completed anonymously helps to allay 
PLHIV’s concerns that information about their HIV status and the 
other issues addressed in the survey may be compromised. 
Secondly, the survey is national. It would not be possible to achieve 
this with a cohort design, since the relative ratios of states and 
territories require adjustment for each survey. The distribution of 
the survey also relies on diffusion through community groups in a 
manner that maintains the anonymity of respondents, particularly 
those in regional areas. 
Thirdly the survey is self-complete. This means that PLHIV can 
complete the survey in a setting that is comfortable and safe for 
them and in their own time. Feedback from participants during 
this study indicated that some people completed the survey over 
a number of days or weeks, and that individuals consulted their 
medical practitioners and other records to verify some of the details 
included in the survey. 
Fourth, the population of HIV positive Australians is constantly 
evolving. A cross-sectional survey allows us to include newly HIV 
positive individuals as well as those who have been positive for some 
time. These groups may have an overall similar experience of living 
with HIV, but the differences between them can be profound. 
There are also certain limitations associated with the recruitment 
method used.
Caution must therefore be exercised in the application of the findings 
of this research to individuals who are less likely to be included in the 
sample, such as people with limited literacy, people of non-English 
speaking background, and those who are particularly geographically 
or socially isolated. We have taken a range of measures to address 
these issues. 
For example, participants were offered the option of completing the 
survey over the telephone either directly with the researchers using a 
free call number, or with service providers. In addition, the Telephone 
Interpreter Service (TIS) was promoted as a way of completing the 
survey for non-English speakers, either by telephone or in person. 
Surveys were also completed with the assistance of service providers 
or community agency workers for those with literacy problems or 
those with physical impairment. The combination of clinical and 
community setting for study recruitment was intended to optimise 
access to the study. This means that people are not disadvantaged 
from entering the study if they are not currently using anti-retroviral 
therapies or not currently in contact with one of the main HIV 
treatment providers. 
Nevertheless it must be acknowledged that this methodology will 
never be appropriate for some members of the PLHIV community. 
This is particularly so for those from culturally and linguistically 
diverse backgrounds who may be marginalised even within their 
own communities, and those for whom invisibility is the key to their 
continuing safety. 
Community development methodologies are currently being 
explored in order to establish how the very real needs of these 
people can be understood and documented over time within an 
action research framework which offers support and strengthens 
networks as the research proceeds. 
It cannot be stressed strongly enough that no piece of research 
should be used in isolation. Each study gives a different perspective 
on the HIV epidemic, and collectively they lead to a greater 
understanding of the dynamics of the epidemic and the issues 
affecting Australian PLHIV. 
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COnSUltAtIOnS 
Consultation around the HIV Futures Study was undertaken  
in three ways: 
1. We engage directly with representatives of our three partner 
organisations: The National Association of People With HIV Australia 
(NAPWHA), The Australian Federation of AIDS Organisations 
(AFAO) and The Australasian Society for HIV Medicine (ASHM). 
These organisations co-ordinate the involvement of their member 
organisations around the country and provide consolidated advice and 
guidance for this project
2. Consultations were conducted with State and national bodies 
in person and by mail prior to the finalisation of the research 
instrument. This included feedback on the survey content and  
on recruitment strategies. 
3. Consultation was also undertaken with key individuals around 
the country including clinicians, treatments officers, mental 
health workers and service providers. Particular consultation 
was undertaken with hepatitis C organisations and clinicians to 
ensure that the expanded hepatitis C section of the survey was 
appropriate and useful. 
wEIGHtInG 
In order to ensure that the results reported in this document 
accurately represent the Australian population of PLHIV, comparisons 
were made to the Australian HIV Surveillance Report (Kirby Institute 
2012) and the data were weighted to conform to the demographic 
profile of the Surveillance Report. A weighting algorithm based on 
mode of infection, gender, state of residence and diagnosis of AIDS 
defining illness has been applied to all the analyses that follow. 
Consequently, findings are presented in terms of sample percentages 
rather than frequencies. Sample sizes (Ns) are given when the table 
represents a subset of the total sample. These Ns are weighted.
AnAlYSIS 
Statistical comparisons including ANOVA and chi-square have been 
employed in the analysis of the data, although for clarity the details 
of these are not included in this report. All significant differences 
reported have a probability of at most α = 0.01. 
fURtHER AnAlYSIS  
AnD REPORtS 
As with the previous HIV Futures surveys, a number of reports and 
specific issues papers analysing specific populations and specific 
issues will be produced over the coming years.
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